rfhg_10951.1

Basic information about the TSS

---

TSS ID: rfhg_10951.1 Species: human Chr: chr1		Start: 112705124 End: 112705148 Strand: -
Source datasets	PRJNA615891|PRJNA401781|PRJNA548673|PRJNA4843412|DRA013844
Protocol	TIF-seq2|SLIC_CAGE|CAGE|RAMPAGE|oligo_capping |ReCappable-seq|NETCAGE
TSS cluster detected*	9

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D2211969,EH38E1377173)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: L25081:-21 GeneID: 389 HGNC/MGI_ID: HGNC:669 UniProt_ID: Nearer transcript ids and distances:

Gene_name: RHOC Gene_symbol: RHOC Gene_synonyms: Gene_source: HGNC:669

TATA-Box annotation

---

Distance to TSS:	1920
Nearest PromoterID:	NM_001042679
Entrez ID:	389
Nearest Unigene:	Hs.502659
Nearest Refseq:	NM_175744
Nearest Ensembl:	ENSG00000155366
Gene Name:	RHOC
Gene Alias:	ARH9|ARHC|H9|RHOH9
Gene Type:	protein-coding
CpG%:	0.041667
GC%:	0.680000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RHOC p2@RHOC p3@RHOC p4@RHOC p5@RHOC
Sample		p1@RHOC	p2@RHOC	p3@RHOC	p4@RHOC	p5@RHOC
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	37.01	5.45	1.95	1.17	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	38.44	5.66	2.83	1.62	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	35.30	4.44	2.31	1.93	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	28.90	4.99	1.87	1.04	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	31.95	4.72	1.35	1.57	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	33.14	4.65	1.36	1.74	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	51.20	3.92	1.09	2.40	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	40.69	3.63	2.66	1.21	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	43.60	2.14	2.14	2.14	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	31.30	4.06	1.74	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	32.34	2.02	1.21	2.02	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	28.05	2.03	0.81	3.25	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	140.88	21.12	9.03	4.51	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	155.91	23.76	8.72	4.51	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	122.07	18.22	10.98	3.73	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	120.21	20.37	8.30	4.02	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	129.73	18.13	9.39	3.28	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	137.09	15.61	7.59	3.37	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	106.10	19.73	4.80	4.80	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	133.89	24.52	10.68	3.76	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	133.38	21.92	8.95	3.47	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	150.87	21.06	7.42	2.76	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	137.01	22.10	7.11	4.52	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	123.28	20.87	9.95	3.40	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	141.38	25.03	6.45	2.84	2.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	140.85	19.31	4.75	3.48	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	121.43	18.13	9.34	2.75	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	155.60	23.81	13.91	6.13	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	128.25	17.28	8.08	3.07	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	133.73	18.10	8.69	3.80	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	143.19	20.52	7.33	2.51	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	135.79	18.56	7.62	2.74	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	130.63	21.52	7.17	5.70	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	152.24	29.52	7.92	2.47	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	127.34	19.45	8.98	4.11	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	133.18	24.14	10.16	4.98	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	128.35	19.42	10.01	2.66	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	128.35	19.95	11.08	1.61	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	128.84	17.56	11.07	4.86	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	114.99	16.56	8.16	4.08	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	130.80	18.11	7.76	3.29	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	139.95	22.11	8.93	3.07	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	107.34	14.34	10.33	4.85	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	121.85	15.38	8.39	2.97	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	121.87	13.85	11.04	4.42	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	110.04	14.89	8.84	3.95	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	112.04	17.51	8.64	5.52	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	111.47	13.11	8.05	3.58	1.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	121.12	13.64	8.14	4.07	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	110.40	17.79	8.09	3.44	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	127.89	13.32	8.61	2.05	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	144.54	14.90	12.90	2.89	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	111.94	13.99	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	147.98	18.45	15.61	4.61	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	137.19	13.92	15.91	1.99	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	104.03	20.97	7.55	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	117.11	18.83	11.94	1.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	140.66	14.26	8.10	4.21	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	134.25	15.42	12.85	3.21	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	123.53	17.29	12.89	1.89	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	138.19	13.40	19.74	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	145.80	20.75	16.82	2.24	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	95.54	7.96	8.76	3.18	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	132.85	9.85	14.27	1.36	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	133.22	10.72	15.60	2.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	174.65	7.10	14.55	3.55	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	193.97	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	252.72	7.90	23.69	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	258.38	9.75	27.30	3.90	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	257.36	6.45	22.81	3.47	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	278.65	7.97	26.74	5.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	239.78	6.95	24.18	1.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	252.73	6.81	15.16	3.09	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	271.50	6.73	19.26	3.67	1.22
Adipocyte - breast, donor1	11376-118A8	175.81	3.64	4.28	10.29	0.00
Adipocyte - breast, donor2	11327-117E4	100.27	2.09	5.29	6.74	0.32
Adipocyte - omental, donor1	11473-119C6	133.59	3.05	2.80	7.89	0.25
Adipocyte - omental, donor2	11474-119C7	127.07	2.99	19.43	7.47	0.00
Adipocyte - omental, donor3	11475-119C8	70.67	3.68	10.72	3.01	0.33
Adipocyte - perirenal, donor1	11476-119C9	126.96	7.02	10.21	4.47	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	100.05	3.30	11.00	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	158.52	3.16	12.65	3.61	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	59.61	4.34	1.56	1.74	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	102.09	5.28	3.52	2.93	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	77.73	2.57	5.15	1.03	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	81.68	3.35	5.02	2.23	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	52.32	7.64	3.53	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	55.26	2.41	2.17	1.77	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	51.64	5.49	1.61	1.29	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	42.66	2.67	2.67	1.07	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	38.95	1.11	0.56	1.67	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	58.64	2.91	4.16	0.83	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	54.75	1.76	2.76	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	48.76	2.29	2.29	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	33.80	0.61	2.44	1.52	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	369.07	3.98	17.24	4.20	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	417.03	6.10	41.95	7.17	1.08
Alveolar Epithelial Cells, donor3	11671-122G6	220.43	9.58	10.78	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	424.94	17.09	23.93	9.53	1.26
Amniotic Epithelial Cells, donor2	11613-122A2	450.17	21.76	18.41	11.71	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	533.75	18.49	20.96	13.56	1.44
Anulus Pulposus Cell, donor1	11248-116E6	217.29	9.73	5.61	5.38	0.92
Anulus Pulposus Cell, donor2	11463-119B5	127.35	6.86	12.00	1.96	1.22
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	194.99	6.74	8.09	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	221.41	4.34	12.59	3.47	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	336.02	10.70	8.56	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	196.69	4.78	9.27	2.99	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	233.96	3.79	12.65	1.26	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	267.33	7.26	4.62	3.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	199.80	5.85	11.70	2.27	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	223.30	5.34	8.25	5.83	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	279.12	4.75	5.94	7.13	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	210.16	6.40	10.55	2.64	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	195.21	3.63	9.43	5.08	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	307.18	6.27	2.51	3.76	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	319.59	5.93	9.39	4.94	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	162.41	1.36	4.09	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	280.02	4.22	10.56	2.41	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	185.38	3.75	9.11	3.21	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	225.78	3.59	12.47	4.35	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	268.62	5.61	8.55	2.94	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	147.29	2.93	4.88	4.88	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	215.62	3.98	14.43	1.82	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	309.79	8.41	6.00	2.40	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	159.31	0.00	7.08	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	207.72	4.97	10.98	4.46	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	272.67	0.00	4.19	8.39	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	214.56	2.91	10.68	6.31	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	231.47	5.69	20.11	4.55	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	254.39	3.63	10.90	6.06	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	195.52	0.00	7.98	2.85	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	234.94	3.42	12.19	3.85	1.07
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	250.86	5.68	10.58	3.36	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	225.22	9.85	11.26	2.82	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	232.48	3.54	13.51	4.50	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	302.50	2.14	7.85	1.43	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	229.89	2.34	11.70	5.85	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	232.73	4.22	11.74	4.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	304.13	9.50	3.56	1.19	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	240.55	6.10	10.68	5.09	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	265.89	5.35	12.73	3.06	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	322.77	6.35	13.34	3.18	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	225.69	4.32	10.79	5.18	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	222.48	5.08	16.51	4.23	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	275.19	4.64	6.96	4.06	1.45
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	170.05	1.89	7.56	1.89	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	231.06	4.41	13.90	3.22	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	266.38	6.95	16.21	9.27	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	145.77	2.11	4.23	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	200.05	3.65	16.94	2.57	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	285.19	7.82	6.02	6.02	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	194.64	2.92	8.02	7.29	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	248.50	4.14	13.56	4.37	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	201.47	5.10	10.20	5.10	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	298.72	5.34	11.69	2.54	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	250.00	3.92	9.91	3.51	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	248.17	5.20	7.04	3.98	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	199.33	3.35	10.52	1.91	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	228.84	2.66	12.20	4.21	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	257.86	9.15	9.15	4.58	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	206.05	2.22	9.97	4.98	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	197.01	2.65	11.65	3.44	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	251.51	6.91	10.18	4.00	1.09
Astrocyte - cerebellum, donor1	11500-119F6	188.03	12.16	15.47	9.70	1.72
Astrocyte - cerebellum, donor2	11580-120F5	214.63	10.61	27.73	6.68	2.23
Astrocyte - cerebellum, donor3	11661-122F5	181.01	21.18	9.02	7.97	2.10
Astrocyte - cerebral cortex, donor1	11235-116D2	166.62	28.24	7.32	8.02	1.39
Astrocyte - cerebral cortex, donor2	11316-117D2	158.70	11.49	4.69	3.56	1.62
Astrocyte - cerebral cortex, donor3	11392-118C6	193.91	11.78	9.55	5.37	1.19
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	20.87	35.44	0.34	0.34	6.31
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	21.55	24.43	0.38	0.25	6.64
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	20.71	25.26	0.34	0.46	5.46
Basophils, donor1	12241-129G9	57.54	8.37	0.78	2.88	0.78
Basophils, donor2	12242-129H1	28.50	16.24	1.80	0.36	1.08
Basophils, donor3	12243-129H2	46.60	4.85	1.47	2.65	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	158.04	12.72	5.17	3.45	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	264.25	10.97	24.69	4.57	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	121.95	50.21	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	286.21	3.77	18.83	6.90	2.51
Bronchial Epithelial Cell, donor5	11457-119A8	229.16	4.37	16.43	4.16	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	141.63	7.60	11.28	2.76	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	86.91	20.51	4.32	2.52	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	6.80	0.00	0.00	1.75
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	0.47	0.00	0.23	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	6.72	8.63	0.00	0.32	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	19.16	1.69	0.00	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	8.91	1.11	0.56	0.37	0.19
CD14+ Monocytes, donor3	11381-118B4	9.88	1.98	0.88	0.22	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	20.66	0.85	1.42	0.85	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	17.82	0.76	1.90	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	23.34	0.33	0.66	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	18.21	0.58	1.16	1.16	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	19.92	0.91	1.21	1.21	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	24.40	0.47	2.61	0.71	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	14.90	0.17	1.17	0.17	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	16.28	0.28	2.21	0.55	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	22.56	0.99	2.48	0.50	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	15.27	0.20	1.57	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	15.85	0.53	0.89	0.36	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	42.22	0.87	1.74	1.09	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	11.47	1.40	0.47	0.47	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	11.09	0.53	2.11	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	26.62	0.00	0.00	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	18.74	0.30	1.04	0.45	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	17.76	0.60	2.39	0.20	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	33.10	1.25	1.87	0.83	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	17.16	0.92	0.69	0.46	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	16.51	0.68	1.36	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	16.15	0.44	0.44	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	16.68	0.81	0.54	0.54	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	23.90	0.87	1.22	0.70	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	33.67	2.10	1.68	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	13.04	0.37	0.92	0.37	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	13.74	1.06	1.06	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	20.18	0.44	0.88	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	25.11	0.70	2.09	0.87	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	19.70	0.37	0.74	1.49	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	42.89	1.51	2.80	0.22	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	17.20	0.41	1.23	1.64	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	13.21	0.93	0.70	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	29.23	0.23	0.93	0.93	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	221.89	4.14	10.24	5.67	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	213.67	5.08	11.09	8.08	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	127.37	2.60	9.10	4.12	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	23.36	0.16	0.93	1.71	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	16.94	0.17	0.17	0.35	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	6.02	0.00	0.67	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	445.02	27.05	15.06	24.50	2.81
CD14-CD16+ Monocytes, donor2	11800-124C9	368.21	23.71	19.32	23.93	1.76
CD14-CD16+ Monocytes, donor3	11911-125G3	313.92	18.32	19.79	16.42	1.68
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	24.39	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	20.34	3.39	2.03	1.36	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	27.96	2.07	2.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	20.79	2.67	1.07	1.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	30.02	5.90	1.61	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	29.48	3.51	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	30.59	3.92	0.00	2.35	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	22.41	5.27	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	6.58	0.82	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	4.35	2.18	0.00	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	6.56	2.02	0.50	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	2.02	0.00	0.00	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	2.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	18.07	4.02	0.00	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	8.99	6.74	0.00	1.12	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	9.39	7.52	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	9.70	9.70	0.68	0.23	0.45
CD4+ T Cells, donor1	11225-116C1	0.00	4.64	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	2.45	11.63	0.00	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	3.05	8.84	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	9.95	9.95	0.77	0.00	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	5.84	7.41	0.45	0.22	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	12.36	11.50	0.00	0.86	1.44
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	1.42	2.84	0.47	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.70	4.92	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	26.01	20.67	0.29	0.29	2.75
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	14.23	11.52	0.34	0.34	1.69
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	19.83	10.96	0.32	0.16	1.29
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	12.55	11.21	0.00	0.00	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	11.53	14.32	0.70	1.05	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	6.16	8.80	0.00	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	29.51	30.36	1.69	0.42	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	32.62	31.58	0.42	0.42	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	43.77	33.08	0.00	0.33	2.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	0.27	2.45	0.00	0.27	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	0.00	2.68	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	0.00	3.59	0.00	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	24.66	15.02	0.37	0.19	1.11
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	20.36	11.26	0.65	0.22	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	25.22	7.99	0.00	0.63	1.89
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	5.06	19.21	0.00	0.51	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	6.93	17.33	0.00	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	3.49	7.41	0.00	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	14.85	25.24	0.99	0.99	1.98
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	14.77	34.16	0.00	2.77	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	33.50	29.31	0.00	1.40	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	14.95	11.63	1.11	0.55	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	15.21	8.59	0.25	0.49	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	20.02	21.56	0.00	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	19.34	26.14	1.07	1.07	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	27.70	48.47	2.77	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	11.46	22.59	0.33	0.33	0.33
CD8+ T Cells, donor2	11307-117C2	7.88	24.78	0.00	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	7.57	9.59	0.25	0.50	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	31.43	9.18	2.29	0.46	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	25.64	5.51	1.20	0.72	1.92
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	31.46	8.21	0.82	0.82	1.09
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	27.32	8.71	3.30	0.60	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	28.08	4.56	2.40	0.24	0.96
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	33.65	8.41	2.05	1.14	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	31.29	7.82	1.30	0.43	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	29.22	7.63	2.11	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	34.24	4.22	0.94	0.70	1.17
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	32.00	7.25	2.11	0.60	3.02
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	33.70	9.88	0.58	1.16	2.61
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	33.04	7.73	1.87	0.80	1.87
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	44.65	5.69	4.38	0.88	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	49.19	7.74	5.01	0.91	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	32.82	3.73	4.48	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	45.02	6.48	3.60	1.08	1.80
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	37.40	7.19	0.86	1.15	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	35.35	8.96	0.94	0.94	1.18
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	43.73	5.70	1.90	0.32	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	31.99	4.31	2.15	1.54	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	33.66	10.26	1.92	0.64	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	26.39	9.56	3.44	0.76	2.68
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	34.29	3.94	3.94	1.18	1.97
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	23.45	7.56	1.51	1.51	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	48.98	4.82	5.62	1.61	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	57.35	7.69	2.10	0.00	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	56.10	4.01	2.00	0.00	3.01
Cardiac Myocyte, donor1	11525-119I4	232.12	7.31	3.66	3.66	0.00
Cardiac Myocyte, donor2	11605-120I3	130.44	2.47	9.88	4.45	0.00
Cardiac Myocyte, donor3	11686-122I3	223.09	6.73	11.05	6.73	0.32
Chondrocyte - de diff, donor1	11261-116G1	149.41	2.43	11.09	4.51	0.00
Chondrocyte - de diff, donor2	11338-117F6	170.23	5.69	9.60	7.46	0.00
Chondrocyte - de diff, donor3	11410-118E6	145.98	10.01	6.94	3.98	0.80
Chondrocyte - re diff, donor2	11339-117F7	213.07	2.69	9.85	1.79	0.90
Chondrocyte - re diff, donor3	11411-118E7	262.46	9.30	12.54	6.87	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	201.17	9.52	7.57	9.64	1.26
Ciliary Epithelial Cells, donor2	11323-117D9	247.11	6.84	8.34	8.12	1.92
Ciliary Epithelial Cells, donor3	11399-118D4	178.68	8.14	9.65	7.17	1.33
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	111.60	10.09	3.21	5.59	0.64
Corneal Epithelial Cells, donor1	11526-119I5	217.16	14.27	9.88	3.95	0.00
Corneal Epithelial Cells, donor2	11606-120I4	83.04	14.79	0.00	1.14	1.14
Corneal Epithelial Cells, donor3	11687-122I4	149.03	14.32	8.44	5.62	1.28
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	54.32	0.00	2.15	0.17	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	59.61	0.00	2.21	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	41.41	0.00	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	42.66	0.22	3.24	0.11	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	36.90	1.02	1.37	0.68	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	38.52	2.61	0.00	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	18.39	2.42	1.94	0.48	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	367.73	3.34	15.18	5.17	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	252.90	4.69	25.23	2.93	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	388.85	3.68	22.34	4.81	1.13
Endothelial Cells - Aortic, donor3	11412-118E8	308.26	4.33	5.90	3.93	0.39
Endothelial Cells - Artery, donor1	11264-116G4	267.60	1.16	30.25	4.65	0.00
Endothelial Cells - Artery, donor2	11341-117F9	359.74	1.88	20.00	5.88	0.47
Endothelial Cells - Artery, donor3	11413-118E9	312.93	2.80	16.13	4.03	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	262.44	3.99	13.52	3.10	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	224.55	2.13	13.39	3.65	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	173.37	0.28	10.15	2.26	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	312.88	3.27	31.79	6.54	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	297.82	3.12	13.54	2.08	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	302.01	5.53	18.43	5.81	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	268.08	2.40	21.21	4.80	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	405.15	5.77	31.97	7.34	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	246.75	2.61	8.08	4.22	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	181.20	1.96	7.82	2.39	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	218.36	2.20	12.82	3.42	0.12
Endothelial Cells - Vein, donor1	11267-116G7	311.68	2.28	36.40	7.96	1.14
Endothelial Cells - Vein, donor2	11344-117G3	298.26	0.70	18.86	4.89	0.00
Endothelial Cells - Vein, donor3	11416-118F3	362.37	2.98	21.82	6.91	0.16
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	4.95	1.65	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	175.43	11.24	8.31	1.95	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	89.45	2.08	6.24	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	81.34	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	200.74	4.93	9.03	3.69	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	231.57	5.91	15.55	5.36	2.08
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	316.67	7.69	16.14	13.22	0.87
Fibroblast - Aortic Adventitial, donor1	11245-116E3	279.55	6.55	9.82	8.61	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	137.84	3.00	7.92	1.77	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	170.97	6.12	6.54	6.33	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	53.75	3.16	8.43	2.37	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	214.60	4.65	10.96	10.96	0.33
Fibroblast - Cardiac, donor1	11268-116G8	219.10	17.69	24.04	6.35	0.91
Fibroblast - Cardiac, donor2	11345-117G4	337.29	6.82	19.71	9.85	1.52
Fibroblast - Cardiac, donor3	11417-118F4	269.06	8.67	15.46	7.57	0.79
Fibroblast - Cardiac, donor4	11452-119A3	111.85	3.03	1.82	3.03	0.61
Fibroblast - Cardiac, donor5	11456-119A7	157.87	2.79	14.72	3.68	0.13
Fibroblast - Cardiac, donor6	11460-119B2	176.61	1.52	18.49	4.24	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	110.01	2.68	12.60	4.15	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	100.09	3.88	10.79	3.45	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	243.16	0.00	16.11	7.32	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	193.28	6.00	11.99	3.00	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	88.87	12.04	3.56	2.04	0.34
Fibroblast - Dermal, donor1	11269-116G9	134.30	2.11	11.74	3.05	0.00
Fibroblast - Dermal, donor2	11346-117G5	197.63	1.89	12.74	3.30	0.47
Fibroblast - Dermal, donor3	11418-118F5	188.10	3.51	9.55	4.71	0.36
Fibroblast - Dermal, donor4	11450-119A1	128.31	2.94	9.95	2.49	0.23
Fibroblast - Dermal, donor5	11454-119A5	146.02	4.54	11.69	4.71	0.35
Fibroblast - Dermal, donor6	11458-119A9	146.34	3.25	13.97	2.44	0.49
Fibroblast - Gingival, donor1	11237-116D4	182.20	5.62	7.91	2.92	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	216.41	7.07	4.72	4.45	0.26
Fibroblast - Gingival, donor2	11318-117D4	196.62	5.93	6.59	3.82	0.92
Fibroblast - Gingival, donor3	11394-118C8	109.64	7.25	6.86	1.55	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	179.73	10.39	6.23	4.16	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	156.12	6.87	5.46	3.52	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	254.27	4.05	8.89	3.90	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	222.85	4.19	7.98	3.65	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	238.19	2.12	7.76	7.76	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	247.59	5.70	6.58	4.24	1.02
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	227.98	4.77	6.54	2.86	0.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	246.15	3.95	8.12	3.18	1.10
Fibroblast - Gingival, donor9 (control)	11927-125I1	139.40	11.01	5.87	1.91	0.44
Fibroblast - Lung, donor1	11270-116H1	213.42	4.08	32.62	1.36	1.36
Fibroblast - Lung, donor2	11347-117G6	146.23	1.49	7.46	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	295.87	5.70	18.57	5.70	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	218.25	2.50	14.99	3.33	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	135.67	1.40	13.99	4.20	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	214.10	8.40	12.03	5.04	0.28
Fibroblast - Mammary, donor1	11540-120B1	244.39	1.22	15.43	1.22	0.41
Fibroblast - Mammary, donor2	11620-122A9	343.50	11.98	19.97	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	184.64	5.96	17.87	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	206.39	4.85	6.01	3.88	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	147.28	3.19	5.01	1.97	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	146.57	4.59	6.12	0.61	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	193.86	3.82	11.45	4.96	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	313.73	8.37	9.72	5.13	1.89
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	149.72	6.84	7.31	4.52	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	357.79	5.64	14.15	8.51	0.99
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	326.53	4.47	14.63	3.86	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	184.42	6.01	8.02	6.01	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	194.91	7.91	9.88	7.91	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	91.48	1.79	9.72	1.98	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	145.11	7.46	7.46	3.91	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	200.63	5.12	9.26	2.96	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	92.36	1.50	12.64	1.81	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	156.10	3.78	14.90	4.21	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	106.04	1.77	13.41	1.01	0.00
Fibroblast - skin normal, donor1	11553-120C5	256.95	9.52	13.95	7.71	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	111.48	0.00	8.02	2.61	0.20
Fibroblast - skin normal, donor2	11561-120D4	213.48	3.52	21.60	7.43	0.40
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	118.17	1.21	10.28	2.42	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	184.00	9.86	5.05	4.47	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	100.52	6.84	13.51	3.42	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	106.74	3.94	14.12	1.31	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	275.57	4.69	23.33	8.31	1.07
Fibroblast - skin walker warburg, donor1	11554-120C6	289.79	5.90	16.02	8.43	1.18
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	277.88	9.57	19.13	5.18	1.57
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	398.88	0.00	44.32	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	27.02	3.49	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	394.91	3.29	10.57	3.29	0.87
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	295.63	3.38	11.71	3.90	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	292.05	2.81	10.99	2.81	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	69.67	9.95	5.36	3.06	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	60.62	12.76	3.83	2.55	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	29.10	12.27	1.14	2.28	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	45.22	8.00	2.48	8.55	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	71.24	11.87	2.74	8.22	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	32.10	9.71	1.39	3.96	0.99
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	50.22	5.29	0.79	7.67	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	46.97	10.44	3.26	5.54	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	17.25	16.36	0.88	1.77	2.65
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	25.01	6.08	1.55	2.97	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	33.99	9.97	2.09	4.19	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	25.79	4.30	2.42	2.69	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	121.91	8.42	5.58	6.57	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	103.96	9.00	4.84	5.12	0.97
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	79.90	5.90	1.42	2.85	1.22
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	151.74	20.54	5.48	9.58	2.28
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	141.26	8.72	9.22	5.98	1.49
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	132.02	5.46	8.74	3.93	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	146.26	37.82	5.32	6.50	1.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	88.22	10.33	4.77	4.29	1.27
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	102.55	16.09	7.37	4.02	1.12
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	97.19	17.95	5.65	5.85	1.61
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	101.45	13.40	5.43	8.48	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	152.25	12.77	2.66	5.41	0.98
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	136.94	26.12	4.58	9.16	2.19
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	124.33	23.91	5.64	5.98	1.54
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	79.89	11.95	6.31	4.43	1.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	132.95	15.72	3.99	4.74	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	122.51	10.82	6.33	5.10	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	107.28	19.81	4.33	8.25	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	71.83	13.95	4.15	6.46	0.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	83.38	12.84	6.67	4.00	1.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	110.88	21.16	7.72	7.49	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	90.52	19.19	7.50	5.78	1.84
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	82.67	17.67	6.65	3.73	0.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	85.95	26.62	3.85	6.09	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	88.03	14.97	5.59	7.39	0.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	99.18	20.09	5.06	4.90	1.74
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	101.57	19.46	4.26	7.30	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	107.57	14.43	6.69	9.20	1.78
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	102.97	20.64	5.05	5.27	1.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	106.61	20.76	3.65	9.54	2.24
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	88.14	5.56	5.09	6.02	0.65
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	106.69	8.29	4.55	4.01	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	103.43	4.44	5.97	6.43	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	112.70	6.99	8.81	6.61	0.91
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	108.97	8.40	6.51	2.98	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	133.84	16.78	7.56	7.37	1.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	151.11	20.62	7.02	9.87	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	48.60	8.93	5.95	4.96	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	184.81	10.16	9.50	8.05	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	166.45	12.91	8.47	6.46	1.41
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	108.27	12.96	3.05	5.59	1.27
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	9.95	3.98	1.00	0.80	1.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	10.01	3.85	0.46	0.92	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	13.91	5.73	1.02	1.02	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	50.07	4.69	1.56	2.50	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	46.62	4.80	2.54	2.83	1.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	20.75	1.84	0.46	0.92	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	47.02	4.95	9.90	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	58.41	5.03	3.09	1.55	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	99.48	8.02	0.00	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	76.51	3.48	3.48	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	69.65	5.86	5.21	2.60	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	66.30	7.82	2.47	4.12	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	53.32	13.33	0.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	74.39	8.95	5.59	2.80	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	81.06	5.23	5.56	2.61	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	45.30	10.07	3.36	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	66.48	7.95	5.73	4.45	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	86.95	6.45	4.42	2.04	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	75.17	8.35	4.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	69.87	7.45	2.29	3.44	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	76.36	8.58	2.96	2.96	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	77.93	8.47	8.47	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	106.45	4.97	4.97	2.49	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	60.75	6.67	4.14	3.91	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	110.64	10.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	81.88	4.23	4.23	4.61	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	92.58	6.52	4.89	3.26	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	104.34	8.69	13.38	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	88.61	10.79	3.47	3.08	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	102.02	5.48	3.77	2.05	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	67.09	19.88	7.45	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	76.44	11.80	7.55	1.89	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	90.52	10.86	8.45	3.62	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	74.78	23.40	5.09	5.60	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	78.17	14.36	5.18	4.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	99.66	15.79	4.44	2.47	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	70.83	22.43	5.90	1.18	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	97.44	19.25	4.08	3.50	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	96.12	18.87	6.58	0.88	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	63.58	24.58	5.09	1.70	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	87.75	15.52	8.36	8.36	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	101.90	18.92	8.73	1.94	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	146.09	2.28	18.26	2.28	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	146.37	5.41	8.32	4.57	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	394.68	2.25	12.37	5.62	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	180.78	9.20	14.27	5.71	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	231.43	13.37	15.87	5.43	1.67
Hep-2 cells mock treated, biol_rep1	11898-125E8	51.64	9.98	1.62	1.51	1.39
Hep-2 cells mock treated, biol_rep2	11899-125E9	45.07	7.93	2.70	1.52	1.35
Hep-2 cells mock treated, biol_rep3	11900-125F1	44.82	8.42	3.41	0.46	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	48.42	11.48	1.64	1.09	0.98
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	43.63	7.09	3.22	0.64	1.29
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	41.55	6.03	3.01	0.86	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	58.91	12.45	2.74	1.99	1.49
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	44.09	8.92	3.43	1.89	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	39.73	6.73	3.84	0.64	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	185.24	2.24	22.38	2.80	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	379.99	4.76	19.91	3.90	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	351.63	2.64	5.29	2.64	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	346.02	11.99	17.28	6.70	1.76
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	360.35	10.17	23.25	3.63	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	216.97	4.37	14.16	5.59	0.70
Hepatocyte, donor1	11523-119I2	44.79	1.21	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	43.09	0.00	5.39	0.00	0.00
Hepatocyte, donor3	11684-122I1	46.63	3.07	4.29	1.23	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	1.31	39.16	0.65	0.00	6.53
Intestinal epithelial cells (polarized), donor1	11246-116E4	66.07	6.64	3.50	2.62	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	167.26	4.25	8.51	2.06	0.69
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	159.19	22.29	28.66	0.00	6.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	126.83	60.08	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	270.83	54.17	27.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	161.97	18.00	15.23	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	152.66	20.02	5.01	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	201.76	23.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	143.52	15.38	10.25	5.13	7.69
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	187.40	18.28	18.28	0.00	9.14
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	185.17	24.36	4.87	3.25	8.12
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	126.72	10.00	10.00	0.00	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	119.81	29.04	7.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	190.58	27.79	6.62	2.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	146.34	26.61	11.09	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	104.77	26.19	26.19	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	159.36	24.56	10.08	0.63	2.52
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	177.86	21.65	9.28	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	73.17	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	187.35	20.67	9.04	3.23	5.81
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	160.99	24.15	19.32	0.00	4.83
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	131.43	23.90	23.90	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	201.27	22.82	13.04	4.89	4.89
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	222.08	31.07	12.17	2.94	3.78
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	158.10	0.00	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	173.60	17.68	11.25	2.41	4.82
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	170.81	24.01	13.85	0.92	4.62
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	75.40	15.08	15.08	0.00	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	168.99	20.77	9.91	1.42	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	121.54	16.33	9.07	1.81	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	162.17	0.00	29.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	170.03	17.22	16.14	0.00	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	185.49	21.60	7.62	0.00	5.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	180.73	16.43	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	174.72	22.32	13.39	1.28	3.83
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	185.91	16.40	20.05	1.82	5.47
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	126.43	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	167.81	24.99	7.85	0.71	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	219.01	13.27	13.27	6.64	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	104.24	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	152.17	12.35	5.56	3.70	1.54
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	142.24	14.05	12.29	0.00	5.27
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	116.30	15.72	3.14	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	147.42	15.30	15.99	0.00	4.17
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	152.70	22.13	26.56	0.00	4.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	100.50	16.21	12.97	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	109.86	19.18	4.36	4.36	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	148.49	11.25	6.75	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	104.54	24.39	10.45	0.00	10.45
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	146.15	16.00	12.80	1.07	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	134.39	8.31	8.31	2.77	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	148.18	11.40	8.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	141.75	14.73	9.20	0.00	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	114.96	39.33	21.18	6.05	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	124.17	0.00	18.63	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	131.11	17.98	13.75	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	230.60	5.79	3.51	3.26	0.65
Keratinocyte - epidermal, donor2	11349-117G8	156.95	7.61	9.37	2.93	0.00
Keratinocyte - epidermal, donor3	11421-118F8	171.52	5.21	6.63	3.69	0.00
Keratinocyte - oral, donor1	11251-116E9	202.63	18.05	6.13	4.88	1.02
Keratocytes, donor1	11527-119I6	210.08	4.13	11.00	5.85	0.00
Keratocytes, donor2	11607-120I5	212.10	12.89	17.58	2.34	0.00
Keratocytes, donor3	11688-122I5	85.76	6.32	5.34	2.96	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	83.52	0.00	6.59	6.59	0.00
Lens Epithelial Cells, donor1	11529-119I8	221.14	4.31	19.42	4.31	0.00
Lens Epithelial Cells, donor2	11609-120I7	132.75	12.57	7.38	8.88	1.15
Lens Epithelial Cells, donor3	11690-122I7	233.61	11.30	12.31	5.45	1.11
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	299.05	5.69	10.67	4.86	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	295.54	2.51	4.47	4.47	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	211.09	1.57	6.45	3.15	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	300.58	3.76	18.28	3.76	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	284.59	3.78	5.36	5.36	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	242.80	3.13	6.68	3.99	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	235.98	4.51	11.08	3.28	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	384.79	4.55	9.61	8.85	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	228.02	2.53	7.04	2.39	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	276.87	5.14	10.28	5.54	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	296.25	1.94	6.79	4.27	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	322.16	2.96	8.33	5.55	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	282.22	5.92	15.33	3.83	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	301.49	1.67	7.39	3.34	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	260.69	2.61	6.46	4.67	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	277.16	4.00	12.93	2.77	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	357.88	4.05	9.04	5.61	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	258.75	2.20	4.57	4.03	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	259.01	5.27	15.80	2.96	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	345.30	2.34	6.44	4.10	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	286.52	3.24	7.72	3.24	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	266.24	3.88	10.67	3.88	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	300.00	3.50	9.96	6.19	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	233.27	1.97	6.21	3.18	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	281.50	3.11	10.89	4.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	287.28	3.77	9.00	4.61	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	242.10	2.86	11.43	5.86	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	295.79	6.19	13.76	4.13	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	323.24	3.01	10.16	4.14	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	255.74	2.23	7.85	5.41	0.53
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	278.15	4.36	13.57	2.42	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	342.70	3.64	8.93	3.97	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	239.48	2.11	8.67	3.47	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	260.63	2.96	11.11	4.07	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	313.55	2.47	6.67	5.44	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	267.15	3.44	7.56	4.81	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	282.72	3.54	12.22	2.57	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	332.63	2.13	9.74	6.09	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	248.58	2.10	7.56	4.76	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	302.58	2.13	13.51	3.20	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	367.95	2.91	10.18	4.85	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	283.05	2.80	7.16	4.36	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	303.67	6.09	15.40	3.94	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	307.07	2.61	10.78	4.25	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	284.86	3.77	6.36	5.89	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	304.18	2.97	10.40	3.34	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	359.35	4.87	6.92	7.68	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	219.29	2.69	15.51	3.88	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	81.58	38.52	2.27	2.27	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	67.51	32.22	12.27	0.77	2.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	66.80	32.66	8.16	4.45	5.94
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	88.43	33.43	3.81	5.50	5.50
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	59.08	37.98	4.22	7.74	5.63
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	70.05	41.09	9.34	4.67	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	75.74	33.49	5.67	4.64	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	59.47	22.60	14.27	2.38	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	113.10	39.36	4.52	7.92	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	73.29	35.48	4.65	5.53	2.91
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	63.47	27.46	11.25	5.40	2.70
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	102.43	41.32	5.28	7.05	4.61
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	92.95	34.41	7.70	6.68	2.05
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	69.87	29.29	6.70	5.29	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	51.97	33.98	7.33	4.66	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	72.33	26.49	4.08	4.08	2.04
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	67.77	21.34	4.80	4.54	2.40
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	87.29	35.14	4.35	5.48	2.65
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	90.19	34.36	4.91	3.68	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	77.47	30.17	13.05	4.89	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	77.05	28.32	3.96	3.96	2.08
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	91.65	30.55	3.92	3.92	3.36
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	65.94	30.91	11.33	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	87.96	34.84	5.52	6.10	4.06
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	72.04	37.07	4.19	5.08	2.69
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	65.84	29.32	6.64	7.19	2.21
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	86.96	34.29	6.72	3.89	3.18
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	84.08	29.50	6.27	3.32	2.58
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	93.25	32.24	6.91	2.30	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	93.25	34.15	8.83	3.45	3.84
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	84.92	34.53	5.10	5.10	4.53
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	79.59	24.61	7.38	4.10	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	98.51	37.51	7.23	5.87	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	78.28	40.93	10.05	4.31	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	77.68	25.39	12.70	5.98	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	69.12	31.59	4.46	2.97	2.97
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	93.04	32.31	4.31	2.58	2.15
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	94.19	29.11	6.85	4.28	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	102.29	41.31	6.33	7.00	3.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	91.10	36.80	7.24	4.83	3.02
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	89.59	34.84	7.11	5.69	2.84
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	93.15	34.03	5.50	3.44	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	84.27	38.11	7.51	4.83	3.22
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	84.17	30.30	10.10	6.73	2.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	97.05	34.45	10.37	1.48	1.48
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	123.27	43.03	4.65	3.49	3.49
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	99.43	28.56	9.52	3.17	3.17
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	105.64	31.21	8.40	6.00	2.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	85.04	32.71	4.36	2.18	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	85.85	41.39	12.26	5.37	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	81.39	46.86	4.93	4.44	1.97
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	74.33	27.29	5.65	2.82	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	75.93	36.20	11.06	8.55	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	88.32	34.70	5.41	2.25	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	84.33	27.54	5.16	3.44	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	84.17	38.30	10.69	5.34	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	79.38	32.85	5.87	5.87	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	76.53	33.65	6.60	3.96	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	85.10	39.96	6.75	8.82	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	80.07	32.82	4.81	5.69	2.19
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	68.21	44.73	3.35	5.59	2.80
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	62.71	32.24	11.04	3.53	3.97
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	80.61	37.80	9.64	7.71	3.47
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	80.51	30.38	8.61	7.60	3.04
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	73.53	31.72	8.17	3.84	3.36
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	87.06	34.98	9.14	5.17	1.59
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	69.88	25.52	5.47	1.82	3.65
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	58.10	11.76	6.92	4.15	3.46
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	94.62	44.08	6.84	2.66	3.42
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	100.70	35.12	2.07	3.61	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	69.54	16.93	6.65	1.81	3.63
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	99.82	32.01	8.87	4.12	2.85
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	89.03	33.58	7.46	5.86	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	63.21	18.96	7.47	4.60	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	104.39	37.54	9.26	5.66	3.09
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	82.76	38.20	9.20	6.37	3.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	77.18	18.16	11.35	3.97	3.40
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	95.27	32.87	5.82	6.66	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	100.23	28.97	3.92	5.48	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	73.07	20.04	11.69	2.92	2.51
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	100.83	35.78	6.50	3.72	1.86
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	89.65	30.11	2.68	3.35	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	62.02	20.85	11.23	3.74	2.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	92.94	40.41	5.66	4.45	1.62
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	91.78	26.62	5.51	3.67	5.51
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	66.68	23.12	7.11	7.11	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	117.39	35.90	9.12	6.27	2.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	103.53	30.68	6.90	6.14	4.60
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	79.89	14.77	6.02	4.38	2.19
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	98.44	30.29	7.13	6.24	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	148.43	34.57	6.50	7.54	1.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	103.44	17.90	14.59	3.32	3.32
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	133.03	33.26	2.08	10.39	4.16
Macrophage - monocyte derived, donor1	11232-116C8	54.02	0.00	0.91	0.46	0.00
Macrophage - monocyte derived, donor2	11313-117C8	92.30	0.00	5.51	0.55	0.18
Macrophage - monocyte derived, donor3	11389-118C3	64.49	0.39	4.19	0.39	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	451.90	4.78	18.05	3.19	1.06
Mallassez-derived cells, donor2	11929-125I3	346.38	4.60	11.25	1.74	0.95
Mallassez-derived cells, donor3	11930-125I4	345.38	5.00	16.54	2.64	1.11
Mammary Epithelial Cell, donor1	11273-116H4	291.46	6.88	9.57	3.79	0.70
Mammary Epithelial Cell, donor2	11350-117G9	192.84	6.37	10.71	2.32	0.00
Mammary Epithelial Cell, donor3	11422-118F9	204.03	8.98	9.98	2.74	0.25
Mast cell - stimulated, donor1	11487-119E2	50.85	1.36	0.68	0.68	2.03
Mast cell, donor1	11563-120D6	34.50	2.81	1.84	0.22	0.43
Mast cell, donor2	11565-120D8	54.68	6.54	3.86	1.19	0.00
Mast cell, donor3	11566-120D9	80.14	6.30	2.70	0.68	0.23
Mast cell, donor4	11567-120E1	55.49	6.38	1.24	0.89	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	36.82	1.00	1.89	0.44	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	67.71	2.33	1.17	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	62.98	3.10	1.38	0.57	0.11
Mast cell, expanded, donor8	11941-126A6	42.18	1.34	2.34	0.17	0.00
Melanocyte - dark, donor1	11502-119F8	151.14	1.59	5.47	1.79	0.10
Melanocyte - dark, donor2	11582-120F7	147.09	6.23	10.38	4.85	0.35
Melanocyte - dark, donor3	11663-122F7	103.95	9.92	5.87	3.55	0.65
Melanocyte - light, donor1	11274-116H5	79.92	4.70	5.88	5.64	0.24
Melanocyte - light, donor2	11351-117H1	79.85	4.78	6.14	2.73	0.00
Melanocyte - light, donor3	11423-118G1	99.73	2.60	12.14	2.60	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	62.79	4.06	5.52	3.96	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	93.86	7.53	3.77	5.11	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	40.71	7.23	3.48	1.07	0.27
Meningeal Cells, donor1	11493-119E8	178.65	1.12	17.37	5.33	0.37
Meningeal Cells, donor2	11573-120E7	150.53	4.84	19.81	7.48	1.76
Meningeal Cells, donor3	11654-122E7	197.64	1.39	5.54	5.79	0.90
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	280.31	4.28	11.41	6.56	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	86.54	7.14	3.12	1.51	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	369.28	9.20	17.08	13.14	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	266.86	3.92	18.31	7.85	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	338.71	1.44	15.79	8.61	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	192.92	11.44	12.28	6.14	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	193.52	3.52	14.07	4.52	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	306.34	9.67	17.58	4.83	1.32
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	301.00	6.58	16.80	1.46	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	306.09	4.91	14.53	6.14	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	139.06	9.28	9.42	3.05	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	282.14	10.41	17.84	3.72	1.49
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	126.97	9.34	4.61	1.32	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	176.26	20.77	11.28	2.67	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	144.80	35.03	14.01	4.67	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	153.06	8.33	5.12	1.28	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	383.51	2.13	20.91	8.15	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	153.23	12.82	5.32	1.88	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	127.00	7.98	8.71	2.18	0.73
Mesothelial Cells, donor1	11247-116E5	403.07	6.10	16.44	4.77	1.06
Mesothelial Cells, donor2	12156-128G5	501.47	11.51	14.01	5.51	1.00
Mesothelial Cells, donor3	11402-118D7	369.63	4.26	19.66	5.78	1.08
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	58.06	0.00	5.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	81.27	0.49	4.68	0.74	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	125.44	1.47	2.94	1.47	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	107.17	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	68.81	0.00	5.27	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	110.35	1.45	4.77	0.21	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	55.59	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	86.34	0.00	6.51	0.50	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	121.02	0.00	3.26	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	76.41	0.41	4.67	0.61	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	131.46	0.00	3.56	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	59.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	70.79	0.88	1.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	162.61	1.52	6.84	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	44.74	0.00	1.32	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	74.28	0.21	3.40	0.64	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	62.62	0.00	2.76	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	56.33	0.30	3.87	0.60	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	65.39	0.00	1.68	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	33.95	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	73.51	0.75	3.51	0.75	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	106.24	0.95	3.33	1.19	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	60.26	0.00	1.66	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	84.27	0.00	6.22	0.00	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	118.00	0.42	5.26	0.42	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	90.09	0.61	6.52	1.43	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	75.95	0.64	4.29	0.43	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	89.14	0.67	3.33	0.89	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	82.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	79.94	0.44	9.20	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	73.51	0.00	4.06	2.53	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	54.68	0.00	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	83.44	0.27	4.62	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	120.87	0.29	2.65	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	61.06	0.00	2.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	126.87	0.96	10.09	0.96	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	140.88	0.80	4.40	0.80	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	71.30	1.37	1.37	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	122.64	1.50	8.01	1.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	61.16	0.00	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	129.19	0.44	8.76	0.44	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	97.12	0.00	7.73	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	56.99	0.00	4.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	120.74	0.99	6.94	0.50	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	77.94	1.39	5.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	59.67	0.00	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	109.06	1.37	6.15	0.68	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	68.27	0.00	7.88	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	52.55	0.36	3.55	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	116.71	0.84	7.57	1.12	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	103.49	0.00	7.90	1.25	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	60.02	0.58	4.66	1.17	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	77.83	0.30	5.73	0.60	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	121.88	0.00	11.69	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	36.09	0.00	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	68.34	0.92	2.77	1.85	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	95.61	0.00	7.97	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	55.00	0.28	3.45	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	81.63	0.00	3.63	0.78	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	84.08	0.86	6.01	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	44.46	0.00	4.45	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	51.78	0.53	2.40	0.80	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	128.41	1.20	10.18	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	44.07	0.00	1.98	0.28	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	77.72	0.32	3.50	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	95.53	1.11	9.73	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	53.09	0.00	3.03	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	58.24	0.57	4.83	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	95.86	0.00	9.34	0.74	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	52.13	0.00	1.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	60.28	0.00	1.47	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	113.02	0.58	9.51	0.29	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	95.21	0.00	0.00	1.24	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	75.93	0.00	7.44	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	45.20	0.00	3.77	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	28.52	0.00	5.35	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	24.64	0.00	1.64	0.66	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	63.12	0.00	5.26	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	35.19	0.00	1.58	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	62.40	0.00	2.79	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	37.18	0.00	2.63	1.50	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	90.02	0.27	8.79	1.60	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	26.69	0.00	1.13	0.34	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	28.00	0.00	3.68	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	23.82	0.00	1.47	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	42.00	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	52.91	0.00	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	34.78	0.00	11.59	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	25.25	0.00	4.04	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	61.14	1.26	5.06	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	47.67	0.00	0.00	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	61.04	0.64	4.45	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	46.16	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	74.01	3.02	6.04	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	22.84	0.00	0.00	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	133.76	0.00	13.05	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	47.52	0.00	9.50	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	330.69	5.82	25.42	11.85	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	120.72	4.18	13.59	9.41	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	153.52	1.33	8.01	1.33	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	153.59	0.83	13.77	4.59	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	202.69	2.66	14.83	3.61	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	210.65	6.38	6.38	3.19	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	90.43	0.68	8.16	0.68	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	139.66	1.84	1.84	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	86.64	1.67	2.93	4.60	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	179.21	1.63	8.37	3.95	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	99.17	3.78	6.49	4.32	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	83.25	3.36	4.41	3.15	0.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	167.02	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	133.02	4.96	4.47	2.98	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	82.01	4.87	4.87	1.89	1.08
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	112.89	4.53	6.57	3.17	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	84.26	5.39	4.57	2.61	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	84.38	3.46	3.83	1.09	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	72.67	6.37	3.71	1.59	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	82.24	1.20	1.20	2.40	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	73.84	13.13	3.28	0.66	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	69.60	3.58	5.37	3.58	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	69.14	3.53	3.35	1.23	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	65.40	4.92	1.41	4.22	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	68.04	4.60	3.22	1.84	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	80.34	8.35	6.75	3.21	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	95.19	12.07	3.45	2.07	1.72
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	108.72	7.59	5.06	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	56.36	4.01	2.90	2.23	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	52.08	4.66	4.23	1.69	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	68.36	7.36	4.03	0.24	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	87.57	9.87	5.15	1.29	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	90.28	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	74.64	11.33	5.00	1.67	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	50.05	4.06	3.16	3.16	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	63.09	3.97	3.17	0.79	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	65.01	10.22	3.71	2.79	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	93.84	14.76	7.19	2.27	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	75.93	8.15	4.24	2.61	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	44.89	7.84	1.74	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	76.44	4.52	4.07	0.45	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	59.97	3.53	2.65	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	60.50	5.32	1.99	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	75.89	16.87	7.94	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	65.85	5.74	3.83	2.30	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	78.64	15.12	4.23	0.60	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	62.33	4.64	2.43	2.43	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	60.99	7.45	2.03	2.71	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	56.20	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	85.97	17.07	3.66	1.83	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	76.17	7.24	5.67	1.89	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	51.15	10.90	5.45	1.82	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	82.28	13.45	11.08	2.37	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	49.88	9.07	2.27	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	116.33	10.12	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	288.21	1.99	10.06	4.72	0.12
Myoblast, donor2	11322-117D8	232.83	6.33	8.06	6.71	0.19
Myoblast, donor3	11398-118D3	194.40	2.19	7.74	4.20	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	20.14	29.62	0.73	0.73	3.21
Natural Killer Cells, donor1	11230-116C6	40.59	18.76	0.62	0.31	1.85
Natural Killer Cells, donor2	11311-117C6	21.71	16.89	0.30	0.00	1.81
Natural Killer Cells, donor3	11387-118C1	29.26	11.60	1.29	0.37	0.18
Neural stem cells, donor1	11275-116H6	159.33	13.07	2.54	9.44	2.54
Neural stem cells, donor2	11352-117H2	48.14	3.85	1.93	3.85	3.85
Neurons, donor1	11494-119E9	52.34	12.52	3.41	1.14	0.00
Neurons, donor2	11574-120E8	71.99	2.64	3.08	5.72	0.00
Neurons, donor3	11655-122E8	45.22	7.40	2.47	3.29	2.47
Neutrophils, donor1	11233-116C9	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	3.05	0.00	0.00	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	117.07	10.33	5.22	2.73	0.95
Nucleus Pulposus Cell, donor2	11409-118E5	205.46	7.16	3.58	6.51	2.28
Nucleus Pulposus Cell, donor3	11462-119B4	133.97	5.41	19.25	3.01	0.80
Olfactory epithelial cells, donor1	11933-125I7	142.33	5.64	7.71	3.58	0.28
Olfactory epithelial cells, donor2	11934-125I8	170.37	5.93	6.08	2.03	1.16
Olfactory epithelial cells, donor3	11935-125I9	147.56	5.68	7.49	2.38	0.57
Olfactory epithelial cells, donor4	11936-126A1	147.46	7.01	6.72	3.21	0.58
Oligodendrocyte - precursors, donor1	11496-119F2	196.80	4.81	10.83	3.61	0.00
Osteoblast - differentiated, donor1	11276-116H7	146.55	11.91	7.23	4.25	1.06
Osteoblast - differentiated, donor2	11353-117H3	177.18	24.01	11.43	10.29	2.29
Osteoblast - differentiated, donor3	11425-118G3	162.01	11.17	11.17	4.97	0.00
Osteoblast, donor1	11277-116H8	439.34	12.12	14.46	13.29	1.95
Osteoblast, donor2	11354-117H4	222.63	4.92	8.43	4.92	0.00
Osteoblast, donor3	11426-118G4	308.01	6.04	12.44	8.00	0.36
Pancreatic stromal cells, donor1	11249-116E7	206.55	4.30	7.58	3.45	0.25
Pericytes, donor1	11491-119E6	113.16	5.01	11.91	5.67	0.56
Pericytes, donor2	11571-120E5	96.43	7.24	14.71	4.30	0.45
Pericytes, donor3	11652-122E5	311.07	6.31	15.67	7.12	1.42
Perineurial Cells, donor1	11499-119F5	208.07	3.50	10.40	5.99	0.34
Perineurial Cells, donor2	11579-120F4	138.66	3.77	5.15	3.04	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	29.32	5.74	0.64	0.32	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	27.42	3.43	0.73	0.73	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	15.01	6.08	1.16	0.52	0.52
Placental Epithelial Cells, donor1	11278-116H9	1076.49	36.11	32.77	30.13	2.63
Placental Epithelial Cells, donor2	11355-117H5	617.65	49.90	16.63	14.42	2.22
Placental Epithelial Cells, donor3	11427-118G5	411.11	56.15	16.49	14.14	4.91
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	284.49	3.16	18.67	13.92	0.95
Preadipocyte - breast, donor1	11467-119B9	168.08	4.88	3.00	10.69	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	113.17	0.78	6.66	1.57	0.13
Preadipocyte - breast, donor2	11328-117E5	188.00	4.05	5.85	14.63	0.68
Preadipocyte - omental, donor1	11468-119C1	164.95	2.88	3.52	9.59	0.75
Preadipocyte - omental, donor2	11329-117E6	187.25	3.93	4.80	8.73	0.00
Preadipocyte - omental, donor3	11403-118D8	187.08	3.87	10.74	7.45	0.57
Preadipocyte - perirenal, donor1	11469-119C2	165.36	2.95	29.53	12.80	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	256.44	1.84	11.36	3.07	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	242.77	0.53	8.15	4.60	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	250.49	2.55	12.43	6.13	0.68
Preadipocyte - visceral, donor1	11280-116I2	227.28	1.21	5.96	4.56	0.19
Preadipocyte - visceral, donor2	11357-117H7	211.68	1.84	4.60	1.84	0.00
Preadipocyte - visceral, donor3	11429-118G7	190.07	0.84	12.43	4.28	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	63.36	6.49	2.26	2.87	0.15
Prostate Epithelial Cells, donor2	11331-117E8	282.20	5.55	9.75	4.06	0.81
Prostate Epithelial Cells, donor3	11404-118D9	79.42	3.80	4.10	2.63	0.12
Prostate Stromal Cells, donor1	11254-116F3	209.92	4.78	7.52	3.42	0.80
Prostate Stromal Cells, donor2	11332-117E9	259.27	4.66	7.71	4.12	0.54
Prostate Stromal Cells, donor3	11405-118E1	208.86	8.86	10.43	4.07	1.04
Renal Cortical Epithelial Cells, donor1	11516-119H4	324.83	11.31	18.98	6.93	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	333.87	6.93	6.93	5.48	0.69
Renal Epithelial Cells, donor1	11517-119H5	445.86	9.13	22.83	11.16	0.00
Renal Epithelial Cells, donor2	11597-120H4	322.23	6.40	18.49	4.27	0.71
Renal Epithelial Cells, donor3	11678-122H4	295.79	6.03	4.34	6.46	0.74
Renal Glomerular Endothelial Cells, donor1	11514-119H2	238.30	4.77	21.11	4.09	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	227.62	1.48	21.97	3.23	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	275.29	3.11	16.87	5.99	1.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	344.03	1.33	17.97	9.32	0.67
Renal Mesangial Cells, donor1	11518-119H6	327.71	10.78	17.61	5.94	0.22
Renal Mesangial Cells, donor2	11598-120H5	290.92	8.15	17.56	4.39	0.00
Renal Mesangial Cells, donor3	11679-122H5	350.09	14.98	22.75	8.04	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	429.74	7.25	22.55	6.17	1.88
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	304.88	8.86	17.29	6.33	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	314.34	5.59	15.43	6.36	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	127.83	13.74	5.19	3.63	2.07
Retinal Pigment Epithelial Cells, donor1	11528-119I7	148.09	11.37	10.80	5.68	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	115.26	8.23	7.20	2.06	3.09
Retinal Pigment Epithelial Cells, donor3	11689-122I6	81.04	6.27	1.76	6.02	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	82.99	3.34	2.54	1.87	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	114.36	14.29	8.04	2.68	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	57.24	20.91	8.81	3.30	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	79.47	19.72	6.38	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	116.37	11.44	9.62	2.08	2.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	154.62	16.78	4.47	3.18	4.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	203.89	21.64	6.13	4.80	5.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	161.75	19.72	9.18	3.10	3.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	183.33	18.65	6.64	4.66	4.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	188.14	18.95	6.24	4.39	2.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	107.75	13.14	12.87	2.74	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	168.37	15.28	5.45	2.72	2.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	228.65	22.04	7.35	4.12	5.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	134.42	15.06	12.62	2.01	3.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	164.94	16.85	6.01	3.33	2.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	184.98	23.01	8.63	3.98	3.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	106.68	11.09	14.15	1.34	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	154.74	14.16	5.68	3.07	2.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	175.88	15.78	3.38	3.95	5.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	110.15	8.63	14.07	2.65	1.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	157.21	15.28	8.96	3.02	3.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	172.24	18.52	6.68	3.06	4.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	122.17	9.29	11.75	2.88	2.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	167.06	22.99	6.17	3.36	3.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	164.58	18.29	7.18	4.27	4.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	120.52	10.94	13.13	2.01	3.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	154.27	15.21	5.52	4.29	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	189.66	22.83	8.46	3.76	3.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	125.01	15.80	17.93	4.95	2.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	155.75	16.67	3.37	3.97	3.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	192.46	27.13	8.42	4.91	4.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	115.50	13.48	12.44	1.45	3.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	149.32	21.01	4.87	4.20	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	176.92	19.01	8.15	3.34	4.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	121.13	14.40	11.31	2.02	2.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	139.47	13.62	8.17	3.24	3.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	142.48	14.07	8.29	3.66	2.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	130.67	12.21	15.47	3.09	2.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	151.71	9.74	5.90	4.39	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	157.27	13.79	5.09	4.43	3.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	121.35	11.25	17.21	2.39	2.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	179.03	16.13	10.95	3.85	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	161.00	14.66	8.80	2.40	4.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	80.06	15.49	11.34	2.77	4.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	149.53	22.14	7.38	2.62	4.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	140.27	24.39	4.64	1.81	4.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	103.59	15.82	9.04	2.54	3.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	149.53	21.66	4.19	5.24	2.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	102.75	22.06	7.86	3.32	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	124.47	15.05	9.30	2.08	3.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	141.33	16.59	6.11	5.53	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	183.14	30.42	12.78	3.65	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	137.44	16.28	11.75	3.01	2.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	171.68	17.64	5.43	6.33	4.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	163.85	20.07	8.09	4.79	2.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	102.02	11.93	9.45	2.95	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	187.40	19.64	8.11	5.12	2.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	149.04	21.03	7.21	5.41	3.00
Schwann Cells, donor1	11498-119F4	274.40	5.83	34.98	11.28	0.56
Schwann Cells, donor2	11578-120F3	231.36	3.40	6.80	6.80	0.00
Schwann Cells, donor3	11659-122F3	207.91	4.38	11.83	7.89	0.66
Sebocyte, donor1	11220-116B5	324.83	10.41	13.15	3.29	1.10
Sebocyte, donor2	11301-117B5	189.34	12.87	5.51	2.30	0.92
Sebocyte, donor3	11378-118B1	106.97	11.75	5.57	4.12	0.82
Sertoli Cells, donor1	11255-116F4	442.31	4.97	18.22	14.91	3.31
Sertoli Cells, donor2	11333-117F1	242.90	16.95	5.65	19.77	0.00
Skeletal Muscle Cells, donor1	11281-116I3	220.74	5.81	6.16	13.99	0.18
Skeletal Muscle Cells, donor2	11358-117H8	121.44	3.61	5.06	2.17	0.00
Skeletal Muscle Cells, donor3	11430-118G8	290.11	1.67	25.08	10.87	1.67
Skeletal Muscle Cells, donor4	11451-119A2	158.98	1.10	13.51	4.56	1.10
Skeletal Muscle Cells, donor5	11455-119A6	136.60	1.64	11.45	4.31	0.74
Skeletal Muscle Cells, donor6	11459-119B1	180.37	2.92	14.16	5.08	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	187.25	5.29	6.80	5.92	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	192.49	4.99	5.85	4.85	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	208.44	3.57	9.13	4.86	0.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	154.60	5.64	4.97	3.96	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	316.28	5.79	18.09	6.51	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	185.21	4.95	15.69	7.16	1.24
Skin - palm, donor1	10286-104F7	29.55	2.69	2.69	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	218.83	5.05	11.96	3.46	1.30
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	114.50	1.64	7.36	1.64	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	189.03	5.19	11.17	4.28	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	261.89	5.00	5.42	4.45	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	155.71	2.11	6.47	3.80	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	111.22	1.48	7.40	1.48	1.27
Small Airway Epithelial Cells, donor3	11406-118E2	105.23	2.77	4.65	4.57	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	236.07	10.80	22.22	8.02	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	53.80	1.11	5.11	1.56	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	399.72	4.70	9.99	6.47	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	260.33	3.98	11.05	5.30	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	442.61	3.94	18.90	6.30	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	391.69	2.32	16.22	6.95	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	103.08	16.01	5.00	2.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	360.77	3.46	15.17	6.12	1.06
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	219.66	5.98	9.75	7.09	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	297.93	6.91	26.50	4.87	0.90
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	206.75	1.95	10.09	5.86	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	218.25	2.66	10.63	6.50	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	299.11	7.40	18.79	4.84	1.42
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	397.09	5.69	23.10	4.55	0.98
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	153.74	4.57	6.39	4.87	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	280.60	5.05	10.86	11.87	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	159.14	0.00	12.24	6.12	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	343.80	6.68	31.95	4.29	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	216.20	9.44	6.78	3.98	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	159.28	8.18	7.32	2.58	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	170.45	6.72	9.87	4.09	0.73
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	420.11	4.02	15.78	7.89	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	531.39	5.39	26.95	9.70	3.23
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	274.65	2.69	19.43	3.59	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	313.40	7.51	22.19	3.76	1.37
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	112.69	9.66	3.38	3.06	0.39
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	184.88	3.93	3.42	7.55	1.01
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	314.02	4.78	15.02	6.14	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	353.23	7.85	24.15	3.62	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	146.50	4.24	8.21	1.06	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	123.31	4.26	13.18	3.06	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	148.13	8.51	5.89	3.13	1.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	142.05	7.36	5.33	3.30	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	403.47	3.02	14.47	10.86	0.90
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	289.56	4.50	12.75	14.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	244.23	2.58	27.14	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	246.95	4.65	13.02	12.09	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	444.30	7.07	12.12	9.09	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	271.09	3.13	20.06	5.33	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	255.47	3.54	8.55	3.54	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	264.92	2.75	11.00	6.00	0.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	165.37	3.74	8.88	2.34	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	339.50	3.74	10.94	5.61	0.72
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	455.61	9.94	19.89	6.88	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	282.05	5.45	22.19	5.45	0.94
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	177.34	5.59	8.66	3.49	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	312.28	11.56	13.74	6.95	0.67
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	162.85	12.86	7.62	2.86	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	330.29	5.87	11.99	4.89	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	193.99	4.20	18.78	3.31	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	323.88	4.68	14.63	3.51	1.17
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	68.22	8.36	6.61	1.75	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	128.00	2.38	8.73	2.38	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	69.55	9.30	8.18	0.74	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	192.96	4.31	11.14	2.16	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	175.73	5.68	10.22	0.57	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	174.88	0.79	11.42	1.97	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	90.41	3.81	6.60	1.78	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	101.43	9.18	6.79	2.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	96.14	8.78	8.36	1.67	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	112.30	8.71	6.42	1.38	0.00
Synoviocyte, donor1	11291-117A4	294.39	5.72	7.74	7.07	0.50
Synoviocyte, donor2	11368-117I9	129.24	4.86	6.37	4.86	0.34
Synoviocyte, donor3	11440-118H9	96.51	4.02	5.14	6.48	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	176.88	8.58	12.15	1.43	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	170.46	11.89	17.84	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	179.91	7.64	7.41	3.70	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	152.76	4.73	4.52	2.29	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	223.43	6.96	11.98	4.25	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	178.67	4.01	12.03	2.29	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	88.09	4.92	2.83	1.60	0.12
Urethra, donor2	10319-105A4	50.36	8.99	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	303.39	7.17	14.88	3.72	0.53
Urothelial Cells, donor2	11600-120H7	209.09	5.61	10.01	2.40	0.00
Urothelial Cells, donor3	11681-122H7	208.35	5.27	8.94	2.52	0.00
Urothelial cells, donor0	11216-116B1	218.66	4.24	7.36	1.34	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	24.02	2.67	1.78	1.78	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	31.45	4.29	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	21.22	3.42	0.68	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	30.65	2.07	1.03	0.34	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	34.28	6.39	1.74	0.58	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	23.95	3.12	0.00	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	27.53	1.84	0.00	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	31.04	2.74	2.74	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	79.44	15.30	6.41	3.58	1.48
Wilms' tumor cell line:HFWT	10597-108E3	47.52	6.16	0.00	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	44.13	10.33	2.79	3.07	0.56
achilles tendon, donor2	10292-104G4	74.40	2.07	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	22.44	8.67	1.53	0.00	3.82
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	4.18	6.73	0.00	0.23	1.86
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	32.17	21.60	0.47	1.54	1.78
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	27.76	37.28	0.54	0.00	9.52
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	5.62	4.78	0.56	0.00	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	69.58	12.69	2.11	0.42	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	41.38	5.44	1.63	1.63	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	20.71	6.17	1.76	0.44	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	6.53	11.43	0.00	0.00	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	4.27	10.48	0.00	0.00	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.18	0.18	0.00	0.00	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	27.30	7.80	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	48.80	10.46	2.32	0.23	1.86
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	2.59	1.29	0.52	0.52	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	2.34	0.58	0.00	0.29	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	7.90	0.46	0.00	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	24.68	1.65	1.23	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	18.72	1.53	1.53	1.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	28.16	3.41	0.43	1.71	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	32.45	5.16	0.61	1.52	1.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	29.13	4.09	1.20	0.48	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	7.57	1.34	0.89	0.22	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	52.03	10.67	2.00	0.33	1.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	26.01	1.86	1.86	0.00	5.57
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	103.96	15.82	3.39	2.26	3.39
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	15.70	10.47	0.00	0.00	1.74
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	13.12	5.62	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	49.93	2.83	3.53	1.65	0.24
adipose tissue, adult, pool1	10010-101C1	112.46	2.95	2.33	4.50	0.16
adipose, donor1	10184-103D4	27.56	6.45	2.35	0.59	0.59
adipose, donor2	10185-103D5	57.18	17.44	1.62	13.79	2.43
adipose, donor3	10186-103D6	94.21	19.06	1.63	11.71	1.09
adipose, donor4	10187-103D7	193.29	7.80	0.87	3.47	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	59.34	15.47	1.10	0.47	4.73
adrenal gland, adult, pool1	10081-102A9	58.20	7.28	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	9.21	93.52	0.13	2.40	8.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	124.34	32.87	4.64	0.71	3.22
amniotic membrane cells, donor1	12235-129G3	283.09	12.52	12.06	7.19	0.70
amniotic membrane cells, donor2	12236-129G4	178.18	41.92	9.80	4.40	0.00
amniotic membrane cells, donor3	12237-129G5	154.67	24.75	6.48	9.43	1.18
amygdala - adult, donor10196	10167-103B5	33.20	2.37	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	58.80	4.46	2.03	3.24	0.41
amygdala, newborn, donor10223	10360-105E9	33.25	1.29	0.32	2.26	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	105.30	8.91	4.84	4.33	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	45.23	22.50	3.31	0.22	2.21
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	32.40	29.06	1.34	1.34	3.01
aorta, adult, pool1	10052-101G7	107.09	11.18	5.49	5.49	0.20
appendix, adult	10189-103D9	60.55	6.21	0.78	2.33	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	5.85	4.47	0.00	0.34	0.69
artery, adult	10190-103E1	58.42	5.43	2.72	2.72	0.00
astrocytoma cell line:TM-31	10425-106D2	138.06	14.34	5.36	5.22	2.46
b cell line:RPMI1788	10427-106D4	9.67	40.60	0.15	0.15	5.65
basal cell carcinoma cell line:TE 354.T	10702-109G9	373.44	5.55	23.03	8.60	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	112.53	6.15	5.06	2.08	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	207.05	28.96	5.02	4.69	2.01
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	10.63	7.83	0.56	1.68	0.00
bladder, adult, pool1	10011-101C2	110.71	10.76	2.06	6.74	0.22
blood, adult, pool1	10053-101G8	24.36	0.00	0.00	2.21	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	264.61	1.71	14.56	6.85	0.00
bone marrow, adult	10192-103E3	108.65	5.40	2.02	2.70	1.35
brain, adult, donor1	10084-102B3	31.78	4.10	0.00	4.10	0.00
brain, adult, pool1	10012-101C3	41.65	3.23	1.45	2.56	0.33
brain, fetal, pool1	10085-102B4	21.37	5.34	0.00	5.34	0.00
breast carcinoma cell line:MCF7	10482-107A5	114.97	40.97	5.29	3.96	1.98
breast carcinoma cell line:MDA-MB-453	10419-106C5	100.98	61.66	3.00	7.61	4.24
breast, adult, donor1	10080-102A8	69.45	1.89	7.58	3.16	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	5.34	2.92	1.02	0.13	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	78.85	36.49	3.40	0.31	2.16
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	53.87	13.81	2.30	0.23	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	37.52	19.61	1.94	0.97	1.21
carcinoid cell line:NCI-H1770	10703-109H1	9.40	8.46	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	63.44	4.38	5.25	3.17	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	13.63	21.55	0.32	2.22	1.58
carcinosarcoma cell line:JHUCS-1	10642-109A3	31.68	4.79	1.60	0.27	0.27
caudate nucleus - adult, donor10196	10177-103C6	35.69	2.30	2.30	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	57.56	3.68	1.00	3.18	0.84
caudate nucleus, adult, donor10258	10379-105H1	32.09	3.82	0.76	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	50.17	2.20	0.37	1.10	0.73
cerebellum - adult, donor10196	10173-103C2	32.05	0.00	5.83	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	38.22	1.71	1.07	2.56	0.00
cerebellum, adult, pool1	10083-102B2	18.63	2.07	0.69	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	22.42	1.66	1.66	0.83	0.00
cerebral meninges, adult	10188-103D8	59.50	4.79	1.51	3.53	0.50
cerebrospinal fluid, donor2	10294-104G6	24.85	2.92	0.73	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	22.57	30.91	0.58	3.16	1.87
cervical cancer cell line:ME-180	10553-107I4	47.23	6.13	0.83	1.49	0.17
cervix, adult, pool1	10013-101C4	114.23	18.16	2.10	4.62	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	190.62	12.68	8.36	4.32	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	86.21	3.92	2.61	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	41.01	16.03	1.37	2.98	0.87
choriocarcinoma cell line:SCH	10785-110H2	51.50	6.28	4.56	1.23	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	40.56	6.40	6.40	0.24	0.24
chorionic membrane cells, donor1	12238-129G6	196.88	10.26	11.11	3.70	1.71
chorionic membrane cells, donor2	12239-129G7	234.66	9.25	13.42	4.47	0.60
chorionic membrane cells, donor3	12240-129G8	108.25	2.75	10.99	1.10	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	26.25	0.00	0.00	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	19.02	4.80	1.73	0.19	1.15
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	21.96	4.65	0.63	0.63	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	73.45	12.84	6.42	0.77	1.54
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	74.50	15.72	2.90	0.73	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	85.52	14.25	5.90	1.22	2.24
chronic myelogenous leukemia cell line:K562	10454-106G4	58.60	19.43	1.47	0.00	2.36
chronic myelogenous leukemia cell line:KU812	10409-106B4	14.07	6.78	0.00	0.52	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	153.38	18.52	4.34	0.91	1.14
clear cell carcinoma cell line:TEN	10636-108I6	69.58	6.59	3.47	1.21	0.69
colon carcinoma cell line:CACO-2	10513-107D9	64.98	5.31	2.38	0.73	0.00
colon carcinoma cell line:COLO-320	10420-106C6	20.90	22.42	0.76	1.14	1.14
colon, adult, donor1	10082-102B1	99.96	9.52	5.95	4.76	1.19
colon, adult, pool1	10014-101C5	171.08	5.52	6.82	6.82	0.24
colon, fetal, donor1	10070-101I7	91.46	6.18	2.47	1.85	0.00
common myeloid progenitor CMP, donor1	12130-128D6	4.58	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	20.40	2.97	1.27	0.42	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	16.45	7.09	0.30	0.45	1.81
cord blood derived cell line:COBL-a untreated	10449-106F8	19.74	10.01	0.42	0.42	3.53
corpus callosum, adult, pool1	10042-101F6	52.52	3.10	1.33	4.53	0.11
cruciate ligament, donor2	10295-104G7	76.99	1.62	0.00	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	63.40	5.62	4.82	1.61	0.00
diencephalon, adult	10193-103E4	32.16	4.08	1.44	1.44	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	1.38	13.78	0.00	0.00	3.44
ductal cell carcinoma cell line:KLM-1	10438-106E6	151.04	27.18	3.33	2.05	3.33
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	65.24	16.13	1.93	1.20	1.44
ductus deferens, adult	10196-103E7	86.71	21.43	3.99	4.49	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	89.29	7.20	2.88	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	115.50	11.03	3.68	3.68	0.00
dura mater, adult, donor1	10041-101F5	105.88	6.85	2.40	6.61	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	50.85	4.22	2.00	5.55	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	97.30	7.16	1.29	6.02	1.00
embryonic pancreas cell line:1B2C6	10604-108F1	69.68	11.72	2.47	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	88.39	16.35	3.63	1.51	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	83.36	7.10	3.40	1.85	0.31
embryonic pancreas cell line:2C6	10603-108E9	77.49	5.25	7.88	2.63	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	107.26	14.75	4.02	2.01	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	381.86	80.11	9.79	6.16	8.52
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	206.64	24.93	8.36	1.93	4.18
epidermoid carcinoma cell line:A431	10426-106D3	87.70	7.56	2.67	1.89	0.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	133.52	5.28	4.84	4.07	0.66
epididymis, adult	10197-103E8	150.91	107.59	6.70	6.70	4.81
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	309.05	22.35	11.35	7.98	3.02
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	43.65	5.90	0.79	2.36	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	40.10	14.15	1.83	1.44	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	35.33	13.19	1.48	1.08	0.59
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	50.41	16.69	1.46	0.78	0.90
esophagus, adult, pool1	10015-101C6	92.06	10.83	3.08	3.93	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	73.89	90.55	3.01	10.14	6.51
eye - muscle inferior rectus, donor1	10272-104E2	57.95	0.00	2.41	4.83	0.00
eye - muscle lateral, donor2	10298-104H1	31.56	0.00	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	31.25	1.49	0.00	2.98	0.00
eye - muscle superior, donor2	10297-104G9	68.79	1.15	1.15	4.59	0.00
eye - vitreous humor, donor1	10268-104D7	51.01	1.46	2.91	5.83	0.00
eye, fetal, donor1	10054-101G9	71.44	8.39	2.29	1.78	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	84.12	7.18	5.26	1.03	1.15
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	127.49	13.53	5.46	1.42	0.47
frontal lobe, adult, pool1	10040-101F4	26.27	2.44	0.56	2.16	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	37.23	7.51	0.60	0.90	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	197.69	6.22	4.85	3.93	0.46
gall bladder, adult	10198-103E9	118.06	8.45	5.07	5.31	0.00
gamma delta positive T cells, donor1	11937-126A2	54.22	41.87	1.07	0.54	1.61
gamma delta positive T cells, donor2	11938-126A3	118.77	22.04	5.23	1.87	3.36
gastric adenocarcinoma cell line:MKN1	10614-108G2	71.18	14.15	4.44	1.69	2.11
gastric adenocarcinoma cell line:MKN45	10612-108F9	35.98	14.31	3.67	0.77	0.19
gastric cancer cell line:AZ521	10549-107H9	39.51	11.97	0.33	0.00	3.61
gastric cancer cell line:GSS	10560-108A2	35.69	5.49	0.00	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	16.68	3.88	0.46	2.06	0.23
giant cell carcinoma cell line:LU65	10487-107B1	29.37	1.49	0.46	2.18	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	96.15	10.64	3.22	1.12	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	47.64	9.23	1.50	1.50	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	184.29	9.82	5.17	2.43	1.69
glioblastoma cell line:A172, tech_rep2	10444-106F3	176.95	6.04	5.34	1.69	1.40
glioblastoma cell line:T98G	10485-107A8	97.46	22.63	2.98	1.88	1.43
glioma cell line:GI-1	10413-106B8	55.06	6.15	3.51	1.46	0.59
globus pallidus - adult, donor10196	10175-103C4	50.29	2.92	2.92	2.92	0.00
globus pallidus, adult, donor10252	10161-103A8	71.03	3.66	2.44	4.88	0.49
globus pallidus, adult, donor10258	10367-105F7	53.40	6.85	4.11	2.74	0.00
globus pallidus, newborn, donor10223	10364-105F4	85.27	2.13	1.07	2.66	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	2.45	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	206.72	5.44	10.24	3.20	0.00
hIPS +CCl2, biol_rep1	14383-156B9	44.99	6.89	3.67	0.92	0.46
hIPS +CCl2, biol_rep2	14384-156C1	32.01	2.74	4.12	0.46	0.46
hIPS +CCl2, biol_rep3	14385-156C2	42.51	0.64	2.58	0.00	1.93
hIPS, biol_rep1	14380-156B6	45.99	4.31	4.31	0.00	1.44
hIPS, biol_rep2	14381-156B7	34.98	1.37	2.06	0.69	0.00
hIPS, biol_rep3	14382-156B8	26.48	2.21	3.31	6.62	0.00
hairy cell leukemia cell line:Mo	10712-109I1	8.05	12.36	0.00	0.00	0.86
heart - mitral valve, adult	10205-103F7	138.12	22.12	3.89	6.28	0.60
heart - pulmonic valve, adult	10206-103F8	83.41	14.64	2.61	5.49	1.05
heart - tricuspid valve, adult	10207-103F9	143.21	4.16	7.49	5.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	108.56	8.37	3.67	4.08	0.82
heart, adult, diseased, donor1	10051-101G6	126.05	12.77	2.98	3.83	0.85
heart, adult, pool1	10016-101C7	163.51	7.82	4.60	5.06	0.46
heart, fetal, pool1	10046-101G1	124.76	24.54	4.21	5.44	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	174.01	2.78	7.10	0.93	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	55.89	2.38	9.51	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	39.12	4.53	1.22	1.22	0.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	43.94	3.88	2.31	1.09	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	46.28	3.94	2.12	1.01	0.10
hepatoma cell line:Li-7	10484-107A7	90.64	3.45	4.11	3.78	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	23.52	34.57	2.11	0.80	2.71
hippocampus - adult, donor10196	10169-103B7	36.91	0.95	0.95	3.79	0.95
hippocampus, adult, donor10252	10153-102I9	61.03	6.53	3.06	3.88	0.20
hippocampus, adult, donor10258	10374-105G5	22.91	1.00	1.49	1.49	0.00
hippocampus, newborn, donor10223	10363-105F3	40.18	0.70	1.06	1.41	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	24.41	10.99	1.22	0.00	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	24.15	8.25	0.39	2.36	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	22.85	9.39	1.02	2.54	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	28.19	4.51	2.82	4.51	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	32.02	6.71	2.07	4.65	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	45.17	7.21	1.90	4.56	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	48.46	13.14	2.92	9.63	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	45.89	16.16	3.66	6.89	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	52.55	14.60	3.34	4.59	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	85.48	18.00	3.79	9.00	1.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	72.48	19.61	3.70	7.39	3.54
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	73.39	11.45	3.37	6.06	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	14.87	11.89	1.56	1.41	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	11.79	12.77	3.93	0.98	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	16.58	14.84	0.87	0.00	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	38.56	4.58	2.10	5.54	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	30.96	2.62	2.62	3.49	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	37.48	5.00	1.50	1.50	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	55.01	29.01	1.70	7.91	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	53.66	31.83	1.36	8.18	4.55
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	56.38	34.46	3.13	11.28	3.13
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	112.84	25.64	3.92	16.17	2.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	102.77	25.55	6.68	17.42	2.61
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	97.45	29.00	2.99	18.83	2.69
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	38.80	7.21	1.11	3.69	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	32.81	8.56	2.28	1.14	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	56.76	13.47	2.04	1.63	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	60.56	9.15	4.58	5.99	2.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	54.80	9.82	2.53	3.80	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	84.73	9.08	3.03	6.36	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	47.06	24.30	2.59	8.27	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	51.14	19.26	7.31	7.97	3.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	57.21	23.60	1.54	9.75	2.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	104.30	21.47	8.18	12.02	2.56
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	68.91	24.23	3.79	18.93	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	120.64	20.16	4.03	10.08	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	30.19	7.00	1.93	1.69	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	33.87	12.03	1.78	1.34	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	30.73	11.22	3.90	2.44	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	48.29	5.50	1.83	4.58	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	84.58	13.01	9.76	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	61.56	13.90	1.32	6.29	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	51.45	21.89	2.74	5.47	3.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	48.13	26.06	3.26	4.34	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	49.82	29.18	3.56	6.41	3.20
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	73.99	16.71	1.19	7.16	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	93.85	20.45	3.11	10.97	1.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	85.94	11.31	3.50	8.35	2.42
immature langerhans cells, donor1	11904-125F5	93.47	0.97	4.36	0.24	0.48
immature langerhans cells, donor2	11905-125F6	70.50	2.38	4.75	0.00	0.00
insula, adult, pool1	10039-101F3	32.27	3.97	0.85	2.65	0.66
keratoacanthoma cell line:HKA-1	10791-110H8	10.08	4.55	0.65	0.98	0.00
kidney, adult, pool1	10017-101C8	192.65	10.31	5.31	4.61	0.90
kidney, fetal, pool1	10045-101F9	98.53	10.82	3.82	4.10	0.64
large cell lung carcinoma cell line:IA-LM	10509-107D5	71.86	6.25	2.98	1.99	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	62.35	4.56	3.87	1.11	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	73.58	13.58	3.85	2.75	0.00
left atrium, adult, donor1	10079-102A7	53.40	13.62	3.81	1.09	0.00
left ventricle, adult, donor1	10078-102A6	113.77	4.55	4.05	2.02	1.52
leiomyoblastoma cell line:G-402	10721-110A1	64.30	13.68	3.28	0.82	0.82
leiomyoma cell line:10964C	10569-108B2	324.04	10.78	9.34	3.59	1.80
leiomyoma cell line:15242A	10570-108B3	281.52	5.43	8.15	5.43	2.17
leiomyoma cell line:15425	10571-108B4	256.41	6.56	6.31	3.40	1.21
leiomyosarcoma cell line:Hs 5.T	10722-110A2	260.32	0.00	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	81.55	4.18	7.32	5.23	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	62.69	10.39	3.78	0.35	0.94
liposarcoma cell line:KMLS-1	10782-110G8	99.19	5.00	4.69	3.12	0.47
liposarcoma cell line:SW 872	10726-110A6	88.46	5.85	6.46	2.31	0.73
liver, adult, pool1	10018-101C9	78.11	1.62	1.46	0.65	0.16
liver, fetal, pool1	10086-102B5	49.86	2.82	1.88	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	61.98	3.79	1.46	1.90	0.00
locus coeruleus, adult, donor10252	10165-103B3	66.07	3.32	2.58	2.03	0.00
locus coeruleus, adult, donor10258	10375-105G6	50.50	5.92	2.54	2.82	0.85
locus coeruleus, newborn, donor10223	10362-105F2	56.78	6.31	1.68	0.84	1.26
lung adenocarcinoma cell line:A549	10499-107C4	43.18	3.60	2.08	0.42	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	103.41	13.79	7.58	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	73.16	7.65	2.90	1.45	0.66
lung, adult, pool1	10019-101D1	165.38	7.09	4.96	3.07	0.35
lung, fetal, donor1	10068-101I5	66.79	4.85	4.28	1.14	0.00
lung, right lower lobe, adult, donor1	10075-102A3	58.19	4.12	2.75	3.21	0.46
lymph node, adult, donor1	10077-102A5	34.56	2.84	0.47	0.47	0.47
lymphangiectasia cell line:DS-1	10727-110A7	35.95	25.64	3.95	0.22	5.26
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	1.21	1.21	0.30	0.00	0.91
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	109.58	5.95	0.00	1.70	0.00
mature adipocyte, donor1	12231-129F8	89.69	0.00	1.78	5.33	0.00
mature adipocyte, donor2	12232-129F9	120.37	0.62	3.11	4.57	0.00
mature adipocyte, donor3	12233-129G1	61.64	0.47	2.13	2.13	0.00
mature adipocyte, donor4	12234-129G2	49.75	0.26	1.58	1.05	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	56.94	12.39	3.34	2.38	3.34
medial frontal gyrus - adult, donor10196	10170-103B8	24.82	1.13	1.13	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	45.42	2.02	1.66	3.13	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	20.01	1.27	0.95	0.95	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	24.74	1.28	2.56	0.43	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	34.09	1.86	0.68	1.18	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	40.11	2.12	2.33	2.97	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	21.19	3.85	0.00	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	28.36	1.08	2.15	1.44	0.72
medulla oblongata - adult, donor10196	10174-103C3	48.02	1.30	1.30	1.30	0.00
medulla oblongata, adult, donor10252	10155-103A2	51.70	5.73	1.70	2.79	0.00
medulla oblongata, adult, pool1	10038-101F2	59.18	5.47	1.22	3.75	0.41
medulla oblongata, newborn, donor10223	10361-105F1	65.62	5.55	1.74	2.43	0.69
medulloblastoma cell line:D283 Med	10838-111E1	11.07	13.95	0.44	1.99	0.44
medulloblastoma cell line:ONS-76	10759-110E3	99.16	7.34	5.38	2.32	1.59
melanoma cell line:COLO 679	10514-107E1	80.07	3.31	4.60	1.01	0.29
melanoma cell line:G-361	10465-106H6	41.81	3.26	2.44	2.17	0.27
meningioma cell line:HKBMM	10691-109F7	144.90	3.44	3.80	4.52	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	0.00	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	3.11	0.78	0.00	0.78	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	173.53	1.99	9.97	4.76	0.77
mesenchymal precursor cell - adipose, donor2	11748-123G2	120.88	1.64	7.82	2.91	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	190.90	1.24	9.52	4.97	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	115.05	1.83	7.16	2.95	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	108.99	5.01	5.58	2.31	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	123.55	4.16	4.16	2.08	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	96.29	3.60	6.18	2.75	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	127.90	2.99	7.94	3.68	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	143.65	2.25	10.35	3.32	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	233.62	2.57	15.80	5.40	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	180.39	1.28	9.82	2.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	86.62	1.65	3.62	1.32	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	166.32	2.08	11.90	2.08	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	260.76	0.70	11.52	3.84	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	210.90	1.22	16.33	3.06	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	124.01	2.16	6.47	0.72	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	163.55	3.31	12.31	2.38	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	232.78	1.82	12.31	3.65	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	175.79	2.10	7.97	3.78	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	129.71	1.79	8.97	1.34	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	157.12	2.36	9.63	2.10	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	112.66	4.42	5.89	1.84	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	152.52	1.72	8.87	3.15	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	277.03	4.63	8.00	5.05	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	167.60	7.31	9.59	9.59	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	175.72	3.58	6.91	5.63	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	201.29	3.14	8.90	8.11	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	176.53	3.70	5.85	9.86	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	176.28	4.00	7.06	7.30	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	179.04	3.38	8.46	8.12	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	197.66	2.36	7.07	11.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	180.72	2.32	4.63	9.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	213.14	3.75	7.21	8.08	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	182.27	2.90	5.58	5.80	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	211.03	4.81	6.25	10.34	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	175.27	1.47	8.80	9.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	174.21	3.02	4.70	10.74	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	173.99	3.28	5.73	5.32	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	171.82	1.29	5.15	6.87	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	254.30	8.20	8.20	8.20	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	273.74	10.33	51.65	10.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	197.79	2.27	10.39	8.77	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	232.80	7.27	18.91	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	248.42	1.07	11.19	7.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	212.62	4.91	10.63	10.63	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	201.75	5.05	10.88	9.33	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	197.28	2.10	8.39	10.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	226.51	3.97	6.95	2.98	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	181.15	0.00	9.53	0.00	9.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	189.16	1.78	11.86	4.74	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	219.32	6.09	7.31	2.44	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	270.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	218.52	3.17	8.23	9.50	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	116.58	4.48	4.48	3.79	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	122.50	0.00	6.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	91.81	7.98	7.98	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	51.66	3.44	6.89	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	61.12	6.11	4.89	3.67	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	70.71	5.56	2.38	4.77	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	56.01	4.13	2.95	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	48.00	7.48	4.68	0.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	45.45	9.36	6.68	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	47.31	4.73	1.18	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	48.79	5.14	5.14	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	61.27	6.20	4.13	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	61.85	3.46	2.47	1.48	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	63.93	4.49	2.24	3.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	47.07	3.18	1.91	3.18	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	78.58	2.01	3.63	1.61	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	65.42	2.18	4.36	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	82.36	2.53	2.53	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	38.84	2.43	4.86	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	49.71	4.52	9.04	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	44.48	1.65	5.77	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	62.70	4.96	1.19	2.98	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	66.85	6.17	2.60	1.95	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	53.99	3.06	3.06	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	173.31	16.25	6.19	4.64	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	290.10	8.98	6.61	1.89	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	92.21	9.73	4.63	1.62	1.39
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	102.57	0.00	8.55	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	166.76	6.78	4.32	1.95	0.92
mesothelioma cell line:Mero-25	10850-111F4	124.14	4.09	9.31	4.99	0.68
mesothelioma cell line:Mero-41	10851-111F5	132.02	3.67	9.05	1.71	0.00
mesothelioma cell line:Mero-48a	10852-111F6	219.22	3.10	11.74	2.21	0.89
mesothelioma cell line:Mero-82	10853-111F7	136.66	6.57	11.30	4.20	0.53
mesothelioma cell line:Mero-83	10854-111F8	141.45	13.11	7.83	3.06	1.02
mesothelioma cell line:Mero-84	10855-111F9	208.54	9.86	9.10	5.31	1.01
mesothelioma cell line:Mero-95	10856-111G1	210.98	9.52	10.77	5.38	2.48
mesothelioma cell line:NCI-H2052	10847-111F1	133.51	0.99	4.80	2.32	0.33
mesothelioma cell line:NCI-H226	10846-111E9	210.31	5.43	9.41	3.08	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	81.48	6.49	3.07	1.88	0.51
mesothelioma cell line:NCI-H28	10845-111E8	73.54	11.20	4.33	1.53	1.02
mesothelioma cell line:No36	10857-111G2	23.49	8.81	1.63	0.65	0.65
mesothelioma cell line:ONE58	10858-111G3	134.39	6.23	5.42	1.90	0.27
migratory langerhans cells, donor1	11901-125F2	193.07	0.38	10.17	0.38	0.19
migratory langerhans cells, donor2	11902-125F3	205.15	0.85	6.47	0.24	0.00
migratory langerhans cells, donor3	11903-125F4	180.56	1.08	7.72	0.90	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	125.04	8.16	4.24	6.53	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	95.58	7.84	6.57	3.18	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	75.56	8.29	5.07	2.30	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	22.84	19.41	1.14	0.19	2.66
myelodysplastic syndrome cell line:SKM-1	10772-110F7	22.36	2.22	0.74	1.29	0.37
myeloma cell line:PCM6	10474-106I6	15.22	3.56	0.59	0.40	0.79
myxofibrosarcoma cell line:MFH-ino	10600-108E6	56.82	7.10	4.57	3.55	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	115.72	3.92	9.81	6.47	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	72.20	6.69	2.01	4.35	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	72.95	8.31	2.50	3.46	0.22
nasal epithelial cells, donor2	12227-129F4	135.24	4.97	3.31	1.10	0.00
neuroblastoma cell line:CHP-134	10508-107D4	0.46	1.61	0.00	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	55.38	7.67	1.31	4.12	1.50
neuroblastoma cell line:NBsusSR	10607-108F4	5.69	4.85	0.00	0.84	0.00
neuroblastoma cell line:NH-12	10555-107I6	3.73	2.42	0.19	0.75	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	0.24	9.96	0.00	0.00	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	8.55	5.54	0.16	0.16	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	2.21	23.35	0.40	0.00	1.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	4.45	6.99	0.64	0.64	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	187.65	3.19	11.18	6.12	0.53
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	8.96	3.55	1.52	0.00	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	55.24	5.60	0.80	2.40	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	141.07	13.47	7.37	5.45	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	223.61	8.41	8.41	4.20	0.79
nucleus accumbens, adult, pool1	10037-101F1	30.00	1.97	0.94	3.09	0.28
occipital cortex - adult, donor10196	10172-103C1	32.97	6.18	0.00	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	56.36	3.49	1.34	1.07	0.00
occipital cortex, newborn, donor10223	10355-105E4	29.48	1.82	1.82	0.73	0.36
occipital lobe, adult, donor1	10076-102A4	17.84	1.57	0.26	1.84	0.26
occipital lobe, fetal, donor1	10073-102A1	10.73	1.29	0.00	0.43	0.43
occipital pole, adult, pool1	10036-101E9	27.04	2.44	0.55	2.60	0.32
olfactory region, adult	10195-103E6	26.37	2.48	1.15	3.44	0.38
optic nerve, donor1	10277-104E7	50.03	4.00	4.00	8.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	107.19	16.06	3.76	3.30	1.25
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	25.55	12.50	0.41	1.79	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	89.57	8.13	2.20	3.05	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	65.72	9.01	4.97	1.04	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	303.37	4.70	12.93	19.11	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	69.14	4.67	3.74	2.80	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	70.83	21.84	2.54	2.33	2.33
ovary, adult, pool1	10020-101D2	98.88	18.69	2.10	11.36	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	101.93	5.13	6.78	2.57	0.00
pancreas, adult, donor1	10049-101G4	38.57	4.70	5.64	1.88	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	55.35	4.19	3.63	1.96	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	84.50	4.77	3.07	5.62	0.85
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	70.21	1.82	2.32	1.66	0.17
paracentral gyrus, adult, pool1	10035-101E8	22.79	2.11	0.82	2.29	0.55
parietal cortex, adult, donor10258	10373-105G4	33.03	2.94	0.73	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	28.21	0.00	0.94	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	35.06	2.57	1.14	1.71	0.57
parietal lobe, adult, pool1	10034-101E7	25.11	2.29	0.88	1.41	0.53
parietal lobe, fetal, donor1	10072-101I9	13.58	1.94	0.00	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	42.25	1.50	1.50	0.75	0.37
parotid gland, adult	10199-103F1	41.93	5.55	1.85	1.85	0.00
penis, adult	10200-103F2	92.38	11.82	4.30	7.52	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	12.64	14.13	0.37	2.05	1.86
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	54.78	4.81	3.06	0.58	0.44
pineal gland - adult, donor10196	10179-103C8	21.93	1.29	1.29	1.29	0.00
pineal gland, adult, donor10252	10160-103A7	20.14	2.37	0.59	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	21.95	3.14	1.88	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	36.42	2.02	4.05	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	35.96	7.82	1.04	6.25	0.52
pituitary gland, adult, donor10258	10378-105G9	21.28	7.66	1.70	1.70	0.85
placenta, adult, pool1	10021-101D3	133.52	5.59	5.05	2.58	0.86
plasma cell leukemia cell line:ARH-77	10840-111E3	24.90	15.49	1.85	0.66	6.22
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	173.54	11.21	7.94	4.05	0.31
pons, adult, pool1	10033-101E6	25.48	1.64	0.69	1.20	0.09
postcentral gyrus, adult, pool1	10032-101E5	23.80	2.79	0.61	1.66	0.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	69.04	8.45	1.89	0.87	1.02
prostate cancer cell line:PC-3	10439-106E7	180.78	7.80	5.99	5.26	1.27
prostate, adult, pool1	10022-101D4	89.69	16.23	2.63	6.53	0.36
putamen, adult, donor10196	10176-103C5	43.91	3.54	2.36	3.54	0.24
putamen, adult, donor10252	10152-102I8	90.19	3.92	1.96	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	31.69	1.09	2.19	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	37.45	1.93	1.45	2.42	0.24
putamen, newborn, donor10223	10365-105F5	30.74	3.00	1.50	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	103.86	14.55	4.95	2.62	0.58
rectum, fetal, donor1	10067-101I4	102.93	15.30	2.78	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	288.74	11.24	8.06	2.97	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	101.48	18.64	0.83	2.49	0.83
retina, adult, pool1	10030-101E3	84.89	18.29	3.88	5.57	0.80
retinoblastoma cell line:Y79	10475-106I7	4.16	9.35	0.00	1.56	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	23.97	6.89	1.11	0.61	0.37
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	56.80	16.59	2.53	0.28	2.81
sacrococcigeal teratoma cell line:HTST	10695-109G2	129.59	3.79	4.55	3.03	0.00
salivary acinar cells, donor1	11771-123I7	101.16	12.14	5.99	1.78	0.81
salivary acinar cells, donor2	11772-123I8	117.72	32.63	6.06	3.86	1.51
salivary acinar cells, donor3	11773-123I9	56.94	19.20	5.30	4.63	1.32
salivary gland, adult, pool1	10093-102C3	22.88	5.15	4.00	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	103.87	7.93	3.04	2.11	0.59
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	102.62	9.05	3.06	3.29	0.59
seminal vesicle, adult	10201-103F3	82.01	28.04	2.12	4.23	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	70.21	22.11	3.16	1.70	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	137.39	3.77	9.81	6.54	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	232.82	1.00	9.03	4.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	52.39	11.42	2.96	1.07	0.67
signet ring carcinoma cell line:Kato III	10436-106E4	70.52	3.65	1.22	3.21	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	109.67	6.32	2.45	1.16	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	29.79	0.00	1.42	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	60.81	2.40	1.32	3.36	0.00
skeletal muscle, fetal, donor1	10066-101I3	97.49	14.07	5.03	2.01	0.00
skin, adult, donor1	10074-102A2	33.93	13.57	0.00	6.79	0.00
skin, fetal, donor1	10065-101I2	51.13	8.84	2.52	0.63	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	24.35	4.00	3.67	0.33	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	11.35	6.93	0.95	0.32	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	21.39	4.05	0.00	1.35	1.16
small cell lung carcinoma cell line:LK-2	10541-107H1	6.26	10.38	0.00	0.16	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	8.20	4.18	0.48	0.48	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	27.46	6.10	3.05	0.65	0.65
small intestine, adult, pool1	10024-101D6	332.89	3.94	13.14	14.33	0.12
small intestine, fetal, donor1	10064-101I1	102.46	5.65	7.62	6.63	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	22.05	1.54	1.54	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	59.96	10.86	2.84	4.14	0.00
somatostatinoma cell line:QGP-1	10781-110G7	38.33	3.75	4.82	0.54	0.00
spinal cord - adult, donor10196	10181-103D1	59.87	3.44	0.92	1.61	0.23
spinal cord, adult, donor10252	10159-103A6	54.02	1.97	2.37	1.97	0.39
spinal cord, adult, donor10258	10369-105F9	30.44	2.77	4.15	2.08	0.00
spinal cord, fetal, donor1	10056-101H2	81.11	14.03	3.05	4.88	1.83
spinal cord, newborn, donor10223	10359-105E8	65.21	3.21	2.30	0.92	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	241.21	1.64	14.04	5.97	0.00
spleen, adult, pool1	10025-101D7	112.34	4.30	4.19	2.42	0.44
spleen, fetal, pool1	10044-101F8	122.28	5.56	5.32	2.62	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	7.25	25.67	0.21	0.21	6.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	52.22	6.65	0.38	0.38	0.95
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	97.15	9.78	3.84	2.10	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	155.98	12.12	7.82	2.35	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	58.31	13.51	1.80	5.74	0.79
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	51.68	19.49	0.85	2.97	1.69
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	64.73	2.54	2.54	0.42	0.85
stomach, fetal, donor1	10062-101H8	87.57	9.61	6.41	5.34	0.00
submaxillary gland, adult	10202-103F4	39.88	4.56	0.57	3.42	0.00
substantia nigra - adult, donor10196	10178-103C7	162.82	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	53.38	2.91	1.87	3.74	0.00
substantia nigra, adult, donor10258	10371-105G2	38.79	0.52	2.07	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	62.89	3.53	2.12	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	50.21	16.74	0.46	3.21	5.04
temporal lobe, adult, pool1	10031-101E4	33.23	3.65	0.85	3.39	0.59
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	13.53	4.99	0.71	1.42	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	23.30	4.40	1.76	2.64	0.00
tenocyte, donor1	11763-123H8	210.51	2.44	17.80	8.38	0.70
tenocyte, donor2	11765-123I1	154.13	2.29	10.68	7.25	0.00
tenocyte, donor3	11768-123I4	223.14	1.85	10.01	7.41	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	62.89	7.48	3.91	1.36	0.85
teratocarcinoma cell line:NCR-G1	10798-110I6	65.82	21.12	4.32	1.23	1.39
teratocarcinoma cell line:PA-1	10807-111A6	17.82	3.41	1.39	1.70	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	17.90	3.55	2.16	0.00	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	13.61	11.35	0.76	0.38	2.27
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	34.68	12.87	2.62	0.65	0.98
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	58.30	12.38	3.58	3.91	1.30
testis, adult, pool1	10026-101D8	132.93	15.03	3.65	7.09	0.86
testis, adult, pool2	10096-102C6	62.25	9.02	2.26	3.16	0.00
thalamus - adult, donor10196	10168-103B6	48.58	0.00	4.42	2.21	0.00
thalamus, adult, donor10252	10154-103A1	47.35	2.50	2.34	1.41	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	47.73	1.54	7.70	1.54	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	32.28	2.96	0.99	1.81	0.66
thalamus, newborn, donor10223	10366-105F6	31.64	4.60	1.15	5.18	2.88
throat, adult	10209-103G2	49.68	8.49	1.50	3.75	0.00
throat, fetal, donor1	10061-101H7	68.86	15.54	3.05	3.35	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	3.38	29.01	0.20	0.60	4.97
thymus, adult, pool1	10027-101D9	25.95	9.25	0.60	1.09	1.19
thymus, fetal, pool1	10043-101F7	46.13	10.60	2.39	0.73	0.73
thyroid carcinoma cell line:KHM-5M	10776-110G2	212.21	2.79	8.24	2.26	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	87.17	14.39	5.31	2.10	0.84
thyroid, adult, pool1	10028-101E1	83.14	25.47	2.89	2.80	0.47
thyroid, fetal, donor1	10060-101H6	58.53	11.86	2.90	0.79	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	92.39	6.16	6.16	0.00	3.08
tongue, adult	10203-103F5	46.75	5.12	1.63	3.49	0.23
tongue, fetal, donor1	10059-101H5	70.15	8.28	4.34	1.97	0.00
tonsil, adult, pool1	10047-101G2	37.77	7.21	1.60	1.90	0.50
trachea, adult, pool1	10029-101E2	93.99	8.51	3.68	3.84	0.33
trachea, fetal, donor1	10058-101H4	78.86	12.69	3.46	0.77	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	192.37	2.13	3.90	3.19	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	59.88	5.27	2.13	3.34	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	50.14	34.63	1.72	1.25	1.88
tridermal teratoma cell line:HGRT	10694-109G1	112.25	1.90	7.61	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	136.71	6.35	8.47	3.05	0.34
umbilical cord, fetal, donor1	10057-101H3	62.60	10.43	6.26	2.09	2.09
uterus, adult, pool1	10100-102D1	75.59	10.92	6.14	3.58	0.85
uterus, fetal, donor1	10055-101H1	94.71	19.45	4.61	2.05	0.00
vagina, adult	10204-103F6	75.61	5.17	3.23	4.52	0.00
vein, adult	10191-103E2	61.38	8.55	1.75	1.97	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	31.24	64.36	2.94	0.27	9.88